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This thesis reports on brain changes in migraine and its possible causes and conse-
quences.  
MIGRAINE 
Migraine is a common, chronic, multifactorial neurovascular brain disorder, affecting 
15% of adults. Migraine is the 3rd most common and 7th most disabling disease in the 
world1, and is responsible for the highest socio-economic burden of any brain disorders 
in Europe1, 2. It is characterized by recurrent attacks of disabling headache and associat-
ed features of autonomic nervous system dysfunction (migraine without aura, MO). Up 
to one third of patients also have neurological aura symptoms (migraine with aura, 
MA).3, 4 For a long time, migraine was believed to be just an episodic disorder without 
permanent effects on health, other than being disabling during the attack. However, in 
the last three decades, associations have been reported between migraine and cere-
brovascular diseases as well as cardiovascular diseases.  
MIGRAINE AND BRAIN CHANGES 
Contrary to being just a harmless condition, in the past decades it has become clear that 
suffering from migraine may have permanent negative consequences to the brain. Ac-
cumulating evidence shows that migraine is linked to the risk of having migrainous in-
farction, ischemic and hemorrhagic stroke, and white matter changes in the brain. 
Migrainous infarction, defined as an ischemic stroke developing during migraine 
with aura, is a rare complication of migraine. In this situation a migraine attack and the 
occurrence of brain damage are directly linked, which suggests a shared pathophysio-
logical pathway. But, although this phenomenon has already first been described long 
ago, the exact pathophysiology is still not yet fully understood.5, 6  
An increased risk of clinical ischemic stroke in migraine patients, irrespective of mi-
graine attacks, has been shown by several epidemiological studies. This increased risk 
notably affects younger women with migraine, in particular those with higher attack 
frequency and MA.7-9  
In addition to clinical infarction, silent cerebral infarcts are also more prevalent 
among migraineurs as was shown by the CAMERA-1 study (the baseline part of the 
CAMERA-study).10 Silent infarcts are defined by the presence of a brain parenchymal 
defect of vascular origin, confirmed by CT or MRI, in the absence of neurological symp-
toms and signs and a history of clinical stroke or TIA.  
From the moment MR imaging became available, studies have reported on white 
matter hyperintense signal abnormalities (WMHs) in migraine patients.11, 12 Most initial 
studies suffered from methodological issues (e.g. selection bias, no IHS-criteria for mi-
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graine diagnosis, etc.) and presented conflicting results, leading to difficulties in inter-
pretation.13 The CAMERA-1 study was designed to overcome these problems, and was 
the first study that provided clear answers. The study showed that migraineurs from the 
general population were indeed at increased risk of posterior circulation territory in-
farcts, and that the higher risk was most pronounced among migraine with aura pa-
tients with a higher attack frequency. Further, women with migraine were found to be 
at significantly increased risk of deep (not periventricular) WMHs. This increased risk 
was not explained by other cardiovascular risk factors. Similarly, infratentorial hyperin-
tense lesions (IHLs) were found to be more prevalent among migraineurs.10, 14-16 These 
findings were subsequently confirmed by other groups17-19  
The CAMERA-1 study also demonstrated that migraine patients have increased iron 
deposition in multiple deep brain nuclei in line with clinic-based studies20-25. The under-
lying mechanisms, however, remained elusive. 
Because the CAMERA-1 study had a cross-sectional design, it was not possible to 
draw any conclusion on a possible causal relationship between migraine attacks and 
brain changes. Therefore, a follow-up study was needed to assess the development of 
new brain changes or progression of existing brain changes over time. 
In the present thesis I describe studies evaluating the incidence and evolution of 
brain changes and associated migraine features in the CAMERA-cohort over a period of 
9 years. In addition, possible causes and functional consequences were assessed. 
In Chapter 2, I describe a study assessing whether migraineurs have a higher inci-
dence and greater volume-increase of WMHs, IHLs and infarcts over time compared to 
a non-migraine control group. We also assessed possible cognitive consequences of 
(progressive) WMLs. In chapters 3 and 4 we describe follow-up study on iron accumula-
tion in the basal ganglia of migraineurs. In chapter 5 we compared other types of struc-
tural brain changes between migraineurs and non-migraine controls by evaluating over-
all and regional gray and white matter structure using state-of-the-art voxel based mor-
phometry analyses. 
POSSIBLE CAUSES 
Now that we know that migraine is associated with several types of brain changes, it is 
important to explore possible causes and consequences.  
One suggested potential cause of brain lesions in migraine patients is the higher 
prevalence of a right-to-left shunt (RLS) in migraine patients. RLS is an abnormal com-
munication between the right (venous) circulation and the left (arterial) circulation. 
Several structural abnormalities can cause right-to-left shunting, although the most 
prevalent cause is a patent foramen ovale (PFO)26, a remnant from the fetal period, 
which is located in the atrial septum of the heart.  
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In the last two decades, several clinic based case-control studies demonstrated a 
two to threefold increased prevalence of RLS in migraine with aura patients, as meas-
ured using Transcranial Doppler with air contrast.27, 28 A recent review reported that 
PFO was more prevalent in migraine with aura patients (pooled OR 2.54; 95%CI 2.01-
3.08)29, but a population based study evaluating the presence of RLS in migraineurs and 
non-migraine controls of the general population was lacking up to that moment.  
Therefore, I describe in Chapter 6 the prevalence of RLS in migraineurs and controls 
of the population-based CAMERA-cohort. RLS has been linked to increased risk of stroke 
in several studies, especially among younger persons.30 In addition, among young is-
chemic stroke patients, those with a RLS are believed to be at higher risk of having mi-
graine with aura.31 It has been suggested that emboli, passing from the venous systemic 
circulation through a RLS to the systemic arterial circulation may both trigger migraine 
aura attacks and may cause (sub)clinical ischemic infarcts, thus providing a possible 
explanation for a link between migraine (aura), RLS and stroke. Supporting evidence for 
this theory was found in a recent study, showing that injecting emboli into the carotid 
artery of mice caused cortical spreading depression, linking emboli to migraine aura.32 
In chapter 6 I also describe the association in the CAMERA-cohort between RLS, ischem-
ic brain lesions and persisting migraine activity. 
POSSIBLE CONSEQUENCES 
It is of great importance to migraine patients to know if brain changes might have func-
tional consequences. In the study described in chapter 2, we assessed cognitive func-
tion in migraineurs with and without brain lesions. 
CEREBELLAR FUNCTION 
Because in the CAMERA-1 study, a higher prevalence of specifically cerebellar located 
infarcts was found among migraine patients, a logical question was whether these le-
sions might have any functional consequence? In other studies, migraine was linked to 
cerebellar dysfunction33-36, possibly due to cerebellar ischemic lesions. These earlier 
studies, however, were clinic-based and thus included patients who were likely more 
severely affected than the ‘average’ migraineurs from the general population. Further-
more, those studies lacked neuro-imaging correlation. In the CAMERA-population, mi-
graine patients show normal cerebellar functions despite having increased prevalence 
of ischaemic lesions in the cerebellar posterior lobe.37 
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Cognitive function 
Clearly, the diagnosis of migraine is not as harmless as was thought before. As described 
above, migraine is linked to the presence and progression of white matter hyperintensi-
ties. In general, in the elderly, WMH have been linked to worse cognitive performance38-
41. Moreover, several papers have described cognitive dysfunction among migraineurs42-
49. Migraine patients often complain about cognitive difficulties during or directly after 
their migraine attacks46, 50 In one of our own studies, migraineurs had no impaired at-
tentional or working-memory functioning in the two days after an attack. They did, 
however, show impairments in the processing of global visual features compared with 
controls, both between and immediately after an attack.51  
Little is known about the effect of WMH on cognitive function in migraineurs. Recently, 
the Epidemiology of Vascular Aging study has evaluated this complex relation and 
demonstrated no evidence that migraine in itself, or in combination with structural 
brain lesions, results in cognitive impairment.17 Chapter 2 of this thesis describes cogni-
tive functioning of the CAMERA-participants with and without migraine and whether 
high WMH load might be associated with reduced cognitive performance. 
AIM OF THIS THESIS 
The general aims of this thesis were: (i) to evaluate the presence and progression of 
brain changes and (ii) to analyze possible causes and consequences for these brain 
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Background. Migraine affects up to 15% of the general population.1-3 One-third of pa-
tients with migraine have associated symptoms of neurological aura.2,3 Previous work in 
the cross-sectional community-based Cerebral Abnormalities in Migraine, an Epidemio-
logical Risk Analysis (CAMERA-1) study demonstrated a higher prevalence and greater 
volume of magnetic resonance imaging (MRI)–measured deep white matter hyperin-
tensities, infratentorial hyperintensities, and posterior circulation territory infarctlike 
lesions in participants with migraine.4-6 A higher volume of deep white matter hyperin-
tensities7 and increased prevalence of posterior circulation territory infarctlike lesions 
has also been demonstrated in women with migraine with aura8 and the prevalence of 
deep white matter hyperintensities was increased among patients with migraine identi-
fied from neurology clinics.9 
Context. A previous cross-sectional study showed an association of migraine with a 
higher prevalence of magnetic resonance imaging (MRI)–measured ischemic lesions in 
the brain. 
Objective. To determine whether women or men with migraine (with and without aura) 
have a higher incidence of brain lesions 9 years after initial MRI, whether migraine fre-
quency was associated with progression of brain lesions, and whether progression of 
brain lesions was associated with cognitive decline. 
Design, Setting, and Participants. In a follow-up of the 2000 Cerebral Abnormalities in 
Migraine, an Epidemiological Risk Analysis cohort, a prospective population-based ob-
servational study of Dutch participants with migraine and an age and sex-matched con-
trol group, 203 of the 295 baseline participants in the migraine group and 83 of 140 in 
the control group underwent MRI scan in 2009 to identify progression of MRI-measured 
brain lesions. Comparisons were adjusted for age, sex, hypertension, diabetes, and 
educational level. The participants in the migraine group were a mean 57 years (range, 
43-72 years), and 71% were women. Those in the control group were a mean 55 years 
(range, 44-71 years), and 69% were women. 
Main outcome measures. Progression of MRI-measured cerebral deep white matter 
hyperintensities, infratentorial hyperintensities, and posterior circulation territory in-
farctlike lesions. Change in cognition was also measured. 
Results. Of the 145 women in the migraine group, 112 (77%) vs 33 of 55 women (60%) 
in the control group had progression of deep white matter hyperintensities (adjusted 
odds ratio [OR], 2.1; 95%CI, 1.0-4.1; P = .04). There were no significant associations of 
migraine with progression of infratentorial hyperintensities: 21 participants (15%) in the 
migraine group and 1 of 57 participants (2%) in the control group showed progression 
(adjusted OR, 7.7; 95% CI, 1.0-59.5; P = .05) or new posterior circulation territory in-
farctlike lesions: 10 of 203 participants (5%) in the migraine group but none of 83 in the 
control group (P = .07). There was no association of number or frequency of migraine 
headaches with progression of lesions. There was no significant association of high vs 
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non-high deep white matter hyperintensity load with change in cognitive scores (−3.7 in 
the migraine group vs 1.4 in the control group; 95% CI, −4.4 to 0.2; adjusted P = .07). 
Conclusions. In a community-based cohort followed up after 9 years, women with mi-
graine had a higher incidence of deep white matter hyperintensities but did not have 
significantly higher progression of other MRI-measured brain changes. There was no 
association of migraine with progression of any MRI-measured brain lesions in men. 
INTRODUCTION 
White matter hyperintensities, infratentorial hyperintensities, and posterior circulation 
territory infarctlike lesions are believed to be of ischemic origin. In particular, white 
matter hyperintensities are associated with atherosclerotic disease risk factors,9 in-
creased risk of ischemic stroke,10-12 and cognitive decline.13 The associations of migraine 
with these MRI-measured lesions and clinical ischemic stroke 7,14 are consistent with the 
hypothesis that recurring migraine headaches may be associated with cerebral ischemia 
and that migraine-associated cerebral ischemia may be attack related. In the current 
study, we report associations of migraine and migraine subtype with the progression of 
MRI-measured cerebral ischemic lesions at the 9-year follow-up of the original CAMERA 
study population. In exploratory analyses, we report associations of migraine frequency, 
total number of migraine attacks during follow-up, and presence of current migraine 
headache symptoms with progression of brain lesions. In additional exploratory anal-
yses, we determined whether progression of brain lesions was associated with cognitive 
decline and whether the presence of migraine headache influenced any association of 
brain lesion progression with cognitive decline. 
METHODS 
Study Population and Procedures 
The original participants of the CAMERA-1 study included 295 well characterized indi-
viduals with migraine3 and 140 age and sex-matched controls who were randomly se-
lected from a community-based study of the general population.1 The MRI scans were 
completed in 2000.4 All participants were invited to return for follow-up scan in 2009. In 
2000, the mean age of the sample was 48 years (SD, 7.8 years) and 71% were women 
(eTable 1, available at http://www.jama.com). The CAMERA-2 study, conducted in 2009, 
included a structured computer-guided telephone interview (programmed using Ishell 
software, World Health Organization), brain MRI, physical examination, and cognitive 
testing similar to the CAMERA-1 protocol. Participants were administered question-
naires to determine previous, current, and newly developed migraine attacks since 
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2000. The interview was structured so that participants could recount their history of 
migraine using personal benchmarks (e.g. pregnancy) for when a different pattern 
started and stopped. These benchmarks were used to define periods. Information was 
collected on migraine prophylaxis and treatment. All non-imaging data were collected 
blinded to diagnosis and MRI findings. To avoid introduction of false-positive differences 
due to upgraded MRI techniques, we used the same scanners and protocols that were 
used for CAMERA-1.4 The protocol was approved by the local medical ethics commit-
tees. All participants gave written informed consent. 
Outcome Measures 
Primary outcome measure of this study was change in number and volume of MRI-
measured deep white matter hyperintensities in individuals with migraine vs controls 
during follow-up. In addition, progression of posterior circulation territory infarctlike 
lesions as well as infratentorial hyperintensities was evaluated. 
Results of automatic segmentation of white matter lesions (QBrain 1.1 software) 
were, if necessary, corrected manually in a conservative manner by 1 rater, in anony-
mized baseline and follow-up scans separately, blinded for scan order and diagnosis. 
Reproducibility data include (random, n = 40 of participants reanalyzed): 1.0T-scanner: 
p, 0.999 (P < .001) and 1.5T-scanner: p, 0.963 (P < .001). Periventricular white matter 
hyperintensities were attached to the lateral ventricle; other supratentorial hyperinten-
sities were deep white matter hyperintensities, which were calculated by number, total, 
and mean volume for each participant. Geographical location was evaluated by normal-
izing the individual MRI scans with segmented lesions to standard Montreal Neurologi-
cal Institute–space, and projecting the lesions (weighted for group size) of all partici-
pants per diagnostic group in a transparent 3-dimensional map (glass brain). 
Infratentorial hyperintensities were hyperintense on T2- and proton-density-
weighted and not hypointense on fluid attenuated inversion recovery images. Presence 
and progression of lesions was diagnosis, by comparing baseline and follow-up scans 
side by side. Reproducibility data (random, n = 40 [14%]; baseline, K = 0.908; P = .09 and 
follow-up, K = 1.000; P < .001). Lesion progression was defined as an increase in size, 
number, or both (Figure 1). 
Infarctlike lesions were nonmass parenchymal defects with a vascular distribution, 
isointense to cerebrospinal fluid signal on all sequences, and, when supratentorial, 
surrounded by a hyperintense rim on FLAIR images.4 Virchow-Robin spaces were ex-
cluded based on typical location, shape, and absence of a hyperintense rim. In the basal 
ganglia, only parenchymal defects larger than 3 mm in diameter were considered in 
order to exclude nonspecific lesions. Location and vascular territory of new and preex-
isting infarcts were read by 2 neuroradiologists, who were blinded to diagnosis (K= 0.87, 
P <.001). All sequences of baseline and follow-up scans were presented side by side 
(angulation corrected and position linked). A third senior neuroradiologist made the 
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final diagnosis in the 9 cases in which the 2 raters disagreed. An exploratory outcome 
measure of this study was the changes in cognition related to white matter hyperinten-
sities at baseline and at follow-up. Similarly, the change in cognition between baseline 
and follow-up was evaluated as function of baseline and follow-up lesion volume as well 
as lesion volume change. For each participant, normalized test scores (Z scores of sepa-
rate tests in domains of memory, executive function, attention, visuospatial ability, and 
speed) were summed to achieve a total composite cognitive score for each time point. 
Change in raw test scores (follow-up minus baseline) were normalized by Z scores. The 
tests, evaluating cognitive performance in the domains of memory, concentration, and 
attention, executive functioning, psychomotor, and processing speed, organization, fine 
motor skills, fluid intelligence, and visuospatial skills, consisted of the 15-word Verbal 
Learning Test15; abbreviated Stroop test,16 consisting of 3 subtasks; verbal Fluency which 
is a modified version of the Symbol Digit Modalities Test; and the Purdue pegboard 
test.19 In follow-up investigation, the Block Design Test from the Wechsler Adult Intelli-
gence Scale III test battery20 was added. Further details on cognition testing are provid-
ed in eTable 3 (available at http://www.jama.com). 
Covariates and Definitions 
Sociodemographic and medical history characteristics were assessed by interview. Edu-
cational level was dichotomized into low, primary school or less than vocational educa-
tion, and high, more than higher vocational or professional education, college, or uni-
versity. A diagnosis of diabetes or hypertension was based on patient report of a physi-
cian’s diagnosis. 
Statistical Analysis 
Differences in the distributions and means of measured characteristics among the study 
groups were assessed with X2, 2-tailed Fisher exact, unpaired t, and Mann-Whitney U 
tests and 1-way analyses of variance where appropriate. Using logistic regression, the 
risk for MRI outcome measures was examined by migraine diagnosis (yes/ no) and sub-
type of migraine (with and without aura vs controls), controlling for age, sex, education-
al level, hypertension, and diabetes. Statistical interactions of hypertension and diabe-
tes for associations of migraine and MRI measured outcomes were tested for by adding 
the interaction terms to the models. Analyses of deep white matter hyperintensity vol-
umes were a priori stratified by sex, based on earlier findings of increased association of 
migraine with MRI lesions only among women.4 Likewise, infarct analyses were a priori 
stratified by anterior or posterior vascular territory. In logistic regression models, ex-
ploratory analyses were conducted on the effects of several migraine characteristics on 
measures of lesion progression. Associations between deep white matter hyperintensity 
load and normalized scores of the baseline and follow-up cognitive tests were assessed 
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using linear regression models, adjusting for age, sex, and educational level (model 1) 
and additionally for migraine (model 2) to assess the effect of migraine diagnosis. Data 
were analyzed using the statistical software package for social sciences (SPSS, version 
17.0. for Windows). 
RESULTS 
Study Population 
A total of 411 of 435 (95%) of baseline participants were successfully recontacted; 14 
participants had moved, 4 were lost to civil registry information, and 6 had died (eTable 1).  
Two hundred eighty-six participants (66%) underwent follow-up MRI scan (114 mi-
graine with aura, 89 migraine without aura, 83 controls). Mean follow-up was 8.5 years 
(range, 7.9-9.2; SD, 0.24 years). Reasons for nonparticipation were no interest (n = 51), 
inability to visit the research center (n = 30), claustrophobia (n = 8), and non-
neurological illness (n = 36). There was no association between responder rate and 
diagnosis of migraine (response rate in both migraine groups was 203 of 296 (69%) vs 
83 of 139 (60%) in the control group (P = .07). Compared with nonparticipants, partici-
pants were younger at baseline (48 vs 50 years; P = .01), more often reported high edu-
cational level (52% vs 40%; P = .01), smoked fewer pack years (8 vs 14 years; P <.001; 
eTable 1), had a similar prevalence of posterior circulation territory infarctlike lesions 
(4%), brain infarcts (6% vs 9%; P = .24), and a high load of deep white matter hyperin-
tensities (based on semi quantitative measures at baseline; 19% vs 22%; P = .44). At 
follow-up, participants in the migraine group were slightly older than those in the con-
trol group (57 vs 55 years; P = .03) and had a higher prevalence of diabetes (9% vs 2%; P 
= .05; TABLE 1). 
Deep White Matter Hyperintensities 
There were no differences in baseline and follow-up white matter hyperintensities be-
tween men in the migraine group and those in the control group (TABLE 2). However, 
among women, both at baseline and follow-up, deep white matter hyperintensity vol-
ume was higher in the migraine group than in the control group (baseline: 0.02 mL vs 
0.00 mL; P = .009; follow-up: 0.09 mL vs 0.04 mL; P = .04). Women in the migraine 
group also had a higher median increase in volume of deep white matter hyperintensi-
ties (mL), as well as a higher incidence of progression (defined as > 0.01 mL) than wom-
en in the control group (yes/no, ≥ 0.01 mL) (77% vs 60%; P = .02). The incidence of deep 
white matter hyperintensity progression was highest among women with migraine 
without aura (83%; Table 2). In multivariate logistic regression analyses involving only 
women, migraine was independently associated with deep white matter hyperintensity 
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progression (adjusted odds ratio [OR], 2.1; 95% CI, 1.0-4.1; P = .04; TABLE 3). Similarly, 
women in the migraine group had a higher incidence of high progression than women 
in the control group (23% vs 9%; P = .03; Table 2). Hypertension was not associated with 
a higher incidence of white matter hyperintensity progression (P = .06). Interaction 
terms for hypertension (P = .90) and diabetes (P = .60) were not significant. Further 
exploratory analyses showed no association of the number of migraine attacks, mi-
graine attack duration, migraine frequency, type of attack, or migraine therapy with 
lesion progression (eTable 2). 
 
Figure 1. Brain Magnetic Resonance T2-Weighted images at baseline and follow-up from three representative 
participants showing progression of infratentorial hyperintensities 
 
Image B shows pontine hyperintensity (arrowhead) increased in size compared with baseline image (A). Image 
D shows new hyperintensities (arrowheads) compared with baseline image (C). Image F shows additional
hyperintensities (arrowheads) compared with baseline image (E). 
Chapter 2 
22 
Table 1. Follow-up Characteristics of Study Participants 
        Migraine 










Age, mean (SD), y 57 (7.7) 55 (7.3) 57 (7.8)f 58 (7.5) 57 (8.0) 
Women 202 (71) 57 (69) 145 (71) 64 (72) 81 (71) 
Maastricht research center 128 (45) 38 (46) 90 (44) 35 (40) 55 (48) 
Low educationa 137 (48) 38 (46) 99 (49) 46 (52) 53 (47) 
BMI, mean (SD) 26 (4.1) 26 (3.8) 26 (4.3) 25 (4.3) 26 (4.2) 
Hypertensionb 97 (34) 24 (29) 73 (36) 32 (36) 41 (36) 
Use of antihypertensive medicationc 79 (28) 19 (23) 60 (30) 28 (32) 32 (28) 
Blood pressure, mean (SD), mm Hgb         
Systolic 151 (21) 152 (19) 151 (21) 148 (20) 154 (22) 
Diastolic 94 (11) 94 (12) 94 (11) 92 (10) 96 (12) 
Diabetes (self-reported) 20 (7) 2 (2) 18 (9)g 9 (10) 9 (8) 
History of stroked 8 (3) 0 (0) 8 (4) 2 (2) 6 (5) 
History of transient ischemic attack 12 (4) 2 (2) 10 (5) 5 (6) 5 (4) 
Smoking           
Ever 193 (68) 58 (70) 135 (67) 58 (65) 77 (68) 
Current 67 (35) 19 (33) 48 (36) 22 (38) 26 (34) 
Pack-years, mean (SD) 11 (15) 12(15) 11 (15) 13 (18) 10 (13) 
Alcohol use           
None during last 12 mo 42 (15) 10 (12) 32 (16) 18 (20) 14 (12) 
≥3 U/d 29 (10) 11 (13) 18 (9) 6 (7) 12 (11) 
Current use of migraine medicatione         
Triptans     25 (12.3) 8 (9) 17 (14.9) 
Ergotamines     5 (2.5) 1 (1.1) 4 (3.5) 
Prophylactic drugs     7 (3.4) 1 (1.1) 6 (5.3) 
Oral contraceptive use, women only         
Current 16 (6) 6 (12) 10 (8) 3 (6) 7 (9) 
≥ 15 y 71 (25) 24 (48) 47 (38) 21 (42) 26 (35) 
Abbreviations: BMI: Body mass index calculated as weight in kilograms divided by height in meters squared.  
a: Low education indicates primary school or lower vocational education. b: Hypertension self-reported 
physician diagnosed. c: Use of antihypertensive medication by participants with hypertension, not used as 
migraine prophylaxis. Mean blood pressure indicates mean of two blood pressure measurements after tran-
scranial Doppler examination with Valsalva maneuver. d: Ischemic or hemorrhage, self-reported. e: current 
use of migraine medication defined as use in the year. f: compared with controls: P=.03. Unless indicated 
otherwise, differences were not significant (P >0.05). g: Compared with controls P=.05 
 
The increase in total deep white matter hyperintensity volume among women with 
migraine was related to an increased number of new lesions rather than intensities at 
follow-up did not differ between groups (P = .97). Participants in the migraine group 
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had a higher incidence of 10 or more new lesions among 43 of 145 participants (30%) vs 
5 of 57 in the control group (9%) (adjusted OR, 3.5; 95% CI, 1.3-9.6; P = 01). Among 
women with migraine, deep white matter hyperintensities were more diffusely distrib-
uted in the deep white matter than among controls (FIGURE 2). 
Periventricular White Matter Hyperintensities 
Progression of periventricular white matter hyperintensities did not differ between 
participants with migraine and controls. There was no association of sex, aura status, or 
migraine frequency with progression. 
Infratentorial Hyperintensities 
The prevalence of infratentorial hyperintensities at follow-up was 21% among women 
with migraine and 4% among controls (adjusted OR, 6.5; 95% CI, 1.5-28.3; P = .01; Table 
3). Progression of infratentorial hyperintensities was not significantly higher among 
women with migraine (15%) than women in the control group (2%; adjusted OR, 7.7; 
95% CI, 1.0-59.5; P=.05; Table 3). There was no relationship between migraine aura and 
number or frequency of migraine attacks with progression of infratentorial hyperinten-
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Table 3. Risk of Deep White Matter and Infratentorial Hyperintensities in Women by Migraine Statusa 




P Value Migraine 
Without Aura  
(n=64) 
Migraine  
With Aura  
(n=81) 
P Value 
Deep white matter 
hyperintensities 









  53 (83) 
 
 
 59 (73) 
 
OR (95% Cl) 1 [Reference]  2.1 (1.0-4.1)f .04  2.9 (1.2-6.7)f 1.7 (0.8-3.5) .23 
High progression, No. (%)c 5 (9) e  33 (23)    19 (30)  14 (17)  
OR (95% Cl) 1 [Reference]  2.3 (0.8-6.4) .12  3.3 (1.1-9.9)f 1.6 (0.5-5.0) .12 
High increase in number, 
No. (%)d 
5 (9) e  43 (30)    25 (39)  18 (22)  
OR (95% Cl) 1 [Reference]  3.5 (1.3-9.6)f .01  5.3 (1.8-15.4)f 2.4 (0.8-7.0) .04 
Infratentorial 
hyperintensities  
Prevalence, No. (%) 
2 (4)  30 (21)    18 (28)  12 (15)  
OR (95% Cl) 1 [Reference]  6.5 (1.5-28.3)f .01  9.6 (2.1-44.1)f 4.4 (0.9-20.5) .07 
Progression, No. (%)b 1 (2)  21 (15)    13 (20)   8 (10)  
OR (95% Cl) 1 [Reference]  7.7 (1.0-59.5) .05 11.5 (1.4-92.9)f 5.0 (0.6-41.7) .10 
Abbreviation: OR, odds ratio. aOR (95% CI) are adjusted for age, education, hypertension, and diabetes. bPro-
gression is defined as an increase in volume after 9 years (delta between follow-up and baseline > 0.01 mL); 
progression of infratentorial hyperintensities is defined as an increase in size, number, or both. cHigh progres-
sion is defined as the upper 20th percentile of progression distribution. dHigh increase in number of lesions is 
defined as 10 or more new lesions, which reflects the upper 20th percentile of the distribution of lesions 
count. eFor analyses of deep white matter hyperintensity progression, 2 women in the control group were 
excluded (leaving n = 55), because of missing baseline volumes due to software failures during lesion segmen-
tations. Visual comparison revealed no progression between baseline and follow-up for these 2 women. 
fCompared with controls: P < .05 
Infarcts and Infarctlike Lesions 
None of the infarctlike lesions present at baseline had disappeared. No significant associ-
ation of migraine with new posterior circulation territory infarctlike lesions existed be-
tween groups (migraine group, 5% vs control group, 0%; P = .07; Table 2). Among partici-
pants in the migraine group, 18 (8.9%) with posterior circulation territory infarctlike 
lesions had a less favorable cardiovascular risk profile than the 185 participants (91.1%) 
without it. Those with infarctlike lesions were older (mean age, 62 vs 57 years; P = .006); 
had higher prevalences of clinically diagnosed stroke (22% vs 3%; P < .001) or hyperten-
sion (67% vs 33%; P = .005), and were more likely taking statins (39% vs 17%; P = .03) or 
platelet inhibitors (33% vs 6%; P < .001). There was no difference between groups for 
new non–posterior circulation territory infarctlike lesions (migraine group, 2.5% vs con-
trol group, 3.5%; P = .69; Table 2). Of those with infarcts, 21% of those in the control 
group vs none in the control group reported a history of clinical stroke (P = .10). 
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Cognitive Changes 
There were no differences in cognitive functioning between groups at follow-up (mean 
composite Z score, migraine group, 1.2 vs control group, 0; adjusted P = .90; 95% CI, 
−2.0 to 2.0). At follow-up, deep white matter hyperintensity load was not associated 
with cognitive performance (mean composite Z score high load, −3.7 vs low load, 1.4; 
adjusted P = .07; 95% CI, −4.4 to 0.2; men and women were analyzed together, see also 
eTable3 for original clinical scores of the separate subtest domains). Presence of mi-
graine did not influence this association (adjusted P = .30; 95% CI, −2.0 to 2.1). Individu-
als with a high deep white matter hyperintensity load at baseline did not experience 
greater change in cognitive function at the 9-year follow-up than those without a high 
load at baseline (mean composite Z score, −0.5 vs 0.2; adjusted P = .4; 95% CI, -1.7 to 
0.7). Similarly, there were no significant differences between groups with respect to 
tests of individual cognitive domains (eTable3). 
COMMENT 
We prospectively evaluated associations of migraine with structure and function of the 
brain at the 9-year follow-up. Among men, we found no association of migraine with 
progression of MRI-measured brain lesions. Women in the migraine group had a higher 
prevalence and a greater increase of deep white matter hyperintensities than women in 
the control group. Although migraine was associated with a higher prevalence of in-
fratentorial hyperintensities at follow up, there were no significant associations of mi-
graine with progression of infratentorial hyperintensities or posterior circulation territo-
ry infarct like lesions among women. In addition, the number of migraines, frequency of 
migraines, migraine severity, type of migraine, and migraine therapy were not associat-
ed with lesion progression. Increase in deep white matter hyperintensity volume was 
not significantly associated with poorer cognitive performance at follow-up. 
This study has several strengths, including the longitudinal study design, length of 
follow-up, the relatively well characterized cohort, use of standardized International 
Headache Society criteria-based diagnosis of migraine by headache experts, and sensi-
tive and reproducible methods of MRI reading. The sensitive MRI techniques used al-
lowed for a more detailed analysis of the brain, in particular the cerebellum. 
Approximately one-third of the original baseline population could not be reinvesti-
gated. This may have introduced selection bias. However, there were no differences in 
baseline MRI parameters between participants and nonparticipants and there was no 
imbalance between the proportions and demographic and clinical characteristics of 
nonparticipating individuals with migraine and controls. Because of differences between 
the semi quantitative baseline reading of deep white matter hyperintensities and the 
current quantitative volume measurements that were not available for the non-
Chapter 2 
28 
responders, additional imputation analyses to support the sensitivity of the current 
results could not be performed. An additional study limitation is that confidence inter-
vals are wide (Table 3). 
The number of migraine attacks, frequency of migraines, migraine severity, type of 
migraine headaches, and migraine therapy were not associated with lesion progression. 
In contrast, our baseline data showed that more frequent migraine headaches were 
associated with a higher prevalence of MRI findings.4 
However, our findings at baseline regarding frequency-related difference in MRI 
findings was most pronounced among those in the migraine group who were 50 years 
or younger and less so in older patients. Thus, with increasing age of the study popula-
tion, when attacks generally diminish,1 other migraine disease-related conditions lead-
ing to white matter hyperintensities are possibly increasing, complicating the detection 
of migraine attack-related associations. A similar, age-dependent mechanism is also 
seen for the risk of stroke in participants with migraine, which is increased in young 
patients only.14,21 At older age, other risk factors such as hypertension may obscure or 
overcome any potential role of migraine. In the present case, we hypothesize there are 
at least 2 different types of vascular mechanisms that may cause structural brain 
changes in migraine: one, which is primarily related to attacks and mainly present at 
younger age, and another, which is probably ongoing as part of having the disease mi-
graine. The observation of migrainous stroke, with stroke occurring during a migraine 
attack, would support the hypothesis that ischemia may occur during attacks.22 Howev-
er, our finding that migraine was not significantly associated with progression of all 
evaluated types of brain lesions at the 9-year follow-up raises questions about the role 
of cerebral ischemia over time in people with migraine.21,23 
Possible explanations for an association of migraine headache with structural brain 
changes include a chronic procoagulatory or proinflammatory state due to endothelial 
dysfunction24,25 or elevated homocysteine levels,26,27 or recurrent paradoxical (micro-) 
emboli due to right-to-left shunts.28 Increased incidence of brain lesions among people 
with migraine headaches and atherosclerotic risk factors such as hypertension, diabe-
tes, or other cardiovascular risk factors is also possible, but we did not identify any sig-
nificant interactions for hypertension or diabetes. A relation with headache in general7 
cannot be excluded. Finally, sex differences seem to play an important role because 
progression of deep white matter hyperintensities was only found in women. This find-
ing is in line with results from another study8 and consistent with the higher risk of brain 
infarcts in women with migraine.14 Our sample size was too small for a proper analysis 
of sex-related differential interaction between migraine and cardiovascular risk factors. 
Participants in the migraine group with posterior circulation territory infarctlike lesions, 
however, did have a less favorable cardiovascular risk profile than those without poste-
rior circulation territory infarctlike lesions. Further research is needed to unravel the 
pathogenesis and relevance of migraine-related structural brain changes and their pos-
sible relation with ischemic events. 
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Figure 2. Geographical Location of All Individual Deep White Matter Hyperintensities Projected on Transparent
3-Dimensional Maps After Normalization of the Individual Magnetic Resonance Scans With Segmented Le-
sions to Standard Montreal Neurological Institute Space 
 
The upper two rows display hyperintensities per study group at baseline and follow-up separately; the lower 
rows show the difference (i.e. progression) between baseline and follow-up in 3 directions. For visualization 
purposes, lesions are displayed after correction for group size, by adjusting their transparency level with a
factor 0.69 for women in the migraine group with migraine with aura (n = 52/n = 75) and 0.91 for female
participants with migraine without aura (n = 52/n = 57), using women in the control group as a reference. 
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White matter hyperintensities have been associated with cognitive deficits in the el-
derly29,30 and some studies found evidence for worse cognitive performance in individu-
als with migraine.31-34 We tested memory, speed, and attention35 in all participants at 
baseline and follow-up and found no significant association between deep white matter 
hyperintensity volume and cognitive dysfunction. Most prior studies were conducted in 
older participants with larger deep white matter intensity volumes; this cohort is rather 
young with relatively little volume.7 
In summary, in a community-based cohort followed up for 9 years, migraine was as-
sociated only with a higher incidence of deep white matter brain changes among wom-
en. There were no significant associations of migraine with progression of other brain 
lesions among women, and there were no associations of migraine headache with pro-
gression of any brain lesions among men. These findings raise questions about the role 
of migraine headaches with progression of cerebral vascular changes. The functional 
implications of MRI brain lesions in women with migraine and their possible relation 
with ischemia and ischemic stroke warrant further research. 
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Assessment of cognitive performance 
Cognitive performance was evaluated by validated, widely used, cognitive tests in a 
fixed order. The test battery, administered by four trained medical students, was the 
same for both time points (test protocol and methods were the same for baseline and 
follow-up) and included the 15 word Verbal Learning Test (Rey, 1985); abbreviated 
Stroop test (Stroop, 1935) consisting of three subtasks; verbal Fluency test (Miller, 
1984); Letter Digit Substitution Test (Van der E, 2006), which is a modified version of 
the Symbol Digit Modalities Test; and Purdue pegboard test (Tiffin, 1948). In follow-up 
investigation, the Block Design Test from the WAIS-III test battery (Wechsler, 1981) was 
added. Higher score indicates better cognitive performance. The results of these tests 
were normalized by calculation of Z-scores based on total sample means and standard 
deviations, and added up per cognitive domain. The composite cognitive score was 
calculated for baseline as well as follow-up time point by adding up the separate do-
main Z-scores.  
Cognitive domains 
Memory function was composed of immediate recall and delayed recall after 20 
minutes. The reading subtasks of the Stroop test measured concentration and attention 
ability. Executive function was scored by the interference task of the Stroop test and the 
word fluency task. The Letter Digit Substitution Test evaluated psychomotor speed, 
processing speed, and organization. Fine motor skills, motor speed, and visuo-spatial 
ability were evaluated by the Purdue pegboard. The Block Design Test measured fluid 
intelligence and visuo-spatial skills. 
Statistical analysis 
Using linear regression, significant difference for cognitive function test scores was 
examined by DWMH load (high vs. non-high) adjusted for age, gender, and educational 
level (model 1). Analyses on the association between high lesion load and cognitive 
performance were done cross sectionally for both CAMERA-1 and CAMERA-2. To assess 
the effect of having migraine on the relation between DWMH load and cognition, mi-
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Iron plays an important role in many biochemical processes. In general, iron is essential 
for proper functioning of the body due to its involvement in oxygen transport, oxygen 
storage, transportation of electrons, glucose metabolism, synthesis of neurotransmit-
ters and myelin, and DNA replication [Connor and Benkovic, 1992;Kell, 2009;Rouault 
and Cooperman, 2006]. The body needs to maintain iron concentrations stable, be-
cause iron shortage as well as iron excess lead to dysfunction. Excess of iron is harmful 
because of its role in the formation of highly reactive hydroxyl radicals, which cause 
damage to all components of a cell, including proteins, lipids, and DNA. The imbalance 
between reactive oxygen species and the ability of the body to detoxify the reactive 
intermediates, or to repair the resulting damage, is called oxidative stress. Oxidative 
stress is involved in many diseases, including neurological diseases. To prevent an ex-
cess of iron, the body regulates the amount of it by changes in uptake, storage and 
release in relation to its need. Recently, the protein hepcidin was found to play an im-
portant role in this process of iron homeostasis by regulating intestinal iron absorption 
[Ganz and Nemeth, 2011]. Ferritin is the protein that serves to store iron in a soluble 
and non-toxic form, to deposit it in a safe form, and to transport it to areas where it is 
required [Maguire et al., 1982]. Ferritin is also involved as a delivery protein in the brain 
[Hulet et al., 1999] and is especially present in larger concentration in the basal ganglia 
[Aquino et al., 2009]. Iron is important for the brain, as the brain requires relative much 
energy and iron is an essential component of ATP synthesis [Gordon, 2003]. In addition, 
iron is essential for the production of lipids and cholesterol and is therefore important 
in the synthesis and metabolism of myelin and neurotransmitters [Levenson and Tassa-
behji, 2004;Thomas and Jankovic, 2004]. Brain iron homeostasis is different from other 
organs because of several brain specific characteristics. First, brain tissue is protected 
from free influx of iron from the plasma by the blood brain barrier [Burdo et al., 
2003;Burdo and Connor, 2003]. This barrier, together with the ventricular system, ac-
tively regulates iron transportation by transferring receptors on capillary endothelial 
cells[Connor, 1994] as well as on endothelial cells of the choroid plexus [Moos, 1996]. 
Second, the concentration of iron varies between different parts of the brain. Brain 
regions with motor function (extrapyramidal regions) contain more iron than non-motor 
parts [Koeppen et al., 1995]. 
IRON AND THE BRAIN 
In 1922, Spatz already recorded the distribution of iron in the different areas of the 
brain by immersion of brain slices in a staining solution (Perl’s stain or the Prussian Blue 
stain). Today, iron in the brain can be detected by using magnetic resonance imaging 
(MRI) and is visible on T2-weighted and T2*-weighted images as hypointensity caused 
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by field heterogeneity and magnetic susceptibility effects [Drayer et al., 1986a;Haacke 
et al., 2005]. A higher load of iron is associated with more hypointensity on the MR 
image [Haacke et al., 2005;Schenck, 1995]. Recent evidence shows a good correlation 
between conclusions on iron distribution in brain areas from post-mortem data and MR 
imaging [Peran et al., 2009a]. In adults, the largest concentration of iron is found in the 
globus pallidus, red nucleus, substantia nigra (including pars reticularis), followed by 
caudate nucleus and putamen. By staining of brain slices as well as by MR imaging, 
infants have demonstrated to have only minimal concentrations of iron in the brain 
[Diezel PD, 1955;Drayer et al., 1986b]. The increase in iron concentration in the brain is 
speculated to be associated with a change in vascularisation [Faucheux et al., 1999]. 
Age-specific iron accumulation in the human brain has been described as early as in 
1958, by Hallgren [Hallgren and Sourander, 1958]. He already demonstrated, by staining 
of brain slices, an increase of especially ferritin in specific brain structures, including the 
globus pallidus and putamen as preferred sites during the first three decades of human 
life [Hallgren and Sourander, 1958]. More recent post-mortem studies have shown 
higher ferritin levels at older age in several basal ganglia, including caudate nucleus, 
putamen, substantia nigra, and globus pallidus [Connor et al., 1995;Zecca et al., 2001]. 
These findings have been confirmed by MR imaging results, demonstrating age-related 
iron increase among these basal ganglia [Bartzokis et al., 1997]. Two recent MRI studies 
on changes in brain iron concentration related to aging show an increase of iron in all 
basal ganglia with increasing age, with specific age-related iron deposition patterns for 
the different structures[Cherubini et al., 2009;Peran et al., 2009b]. For instance, the 
globus pallidus shows a clear increase of iron concentration from childhood into adult-
hood. Substantia nigra already contains more iron than the globus palidus at younger 
age and increase follows a steeper curve, whereas both putamen and caudate nucleus 
show a much slower rate of iron increase with aging [Aquino et al., 2009]. Furthermore, 
iron increase follows a precise accumulation direction from posterior to anterior and 
from medial to lateral parts of the basal ganglia [Aquino et al., 2009]. Below the age of 
15 years, iron accumulation is largest in the medial part of the internal globus pallidus, 
whereas it is largest in the lateral part between the ages of 15-30 years of age [Aquino 
et al., 2009]. Mechanisms responsible for early accumulation in the substantia nigra and 
globus pallidus are not clear, but it could be the result of preferential or abnormal local 
neuronal uptake of iron [Bartzokis et al., 1997], abnormal transportation of iron along 
white matter pathways connecting these nuclei [Drayer et al., 1986a;Aoki et al., 1989] 
or it is based on a decreased efficiency of the usual iron transport from the basal ganglia 
to areas elsewhere due to age-related loss of neurons [Dietrich and Bradley, Jr., 
1988;Cross et al., 1990]. After the age of 50 years, all basal ganglia show a large variabil-
ity between subjects for hypointensity on MRI, because the T2 values of deep nuclei are 
significantly influenced by non-iron-related tissue changes, such as myelin loss or an 
increase in water content associated with microvascular changes [Aquino et al., 
2009;Bartzokis et al., 1997;Schenker et al., 1993]. Despite the large variability of brain 
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iron accumulation among elderly subjects, it has been suggested that if hypointensity is 
found in the caudate nucleus, this could be a sign of central nervous system disease 
instead of being part of a normal aging process [Milton et al., 1991]. This was confirmed 
by a recent MRI study among elderly subjects which described presence of hypointensi-
ty of the caudate nucleus to be associated with the presence of a higher load of age-
related cerebral changes, like more atrophy and a higher load of white matter hyperin-
tensities [van Es et al., 2008]. Iron excess in the basal ganglia is damaging, because it 
increases the tissue’s susceptibility for apoptosis and inflammation, it could lead to 
basal ganglia dysfunction due to decreased protein synthesis, and the tissue becomes 
more vulnerable for the damaging effect of reactive oxygen species. This destructive 
process is being summarized by Zecca as iron accumulation, invasion and increased 
reactivity [Zecca et al., 2004].  
IRON AND NEUROLOGICAL DISORDERS 
Increased iron levels in pathological relevant brain structures and iron-mediated oxida-
tive stress are associated with several neurological disorders, including Parkinson dis-
ease, Alzheimer disease, Huntington disease, Friedreich ataxia, Amyotrophic Lateral 
Sclerosis, Neurodegeneration with Brain Iron Accumulation (formerly Hallervorden-
Spatz syndrome), and also migraine. Every disorder has its specific mechanisms and 
locations of brain iron accumulation. 
In Parkinson disease, iron excess has been demonstrated in the substantia nigra 
[Sian-Hulsmann et al., 2010;Kell, 2010;Bartzokis et al., 1997;Sian-Hulsmann et al., 
2010;Kell, 2010;Gotz et al., 1990;Gorell et al., 1995;Ryvlin et al., 1995] and was found to 
be associated with local oxidative stress, as indicated by protein disruption [Goodwin et 
al., 2000] and oxidative DNA damage [Sanchez-Ramos et al., 1987;Alam et al., 
1997;Poon et al., 2004a;Poon et al., 2004b]. 
In the brains of patients suffering from Alzheimer disease, iron accumulation occurs 
without the normal age-related increase in ferritin, thereby increasing the risk of oxida-
tive stress [Zecca et al., 2004]. Iron excess is found early in the disease process in sever-
al brain structures, including the basal ganglia [Connor and Benkovic, 1992;Bartzokis et 
al., 1997;Bartzokis and Tishler, 2000;Bartzokis et al., 2000]. Although the origin of ele-
vated brain iron levels is unclear, the role of iron is apparent: both senile plaques and 
neurofibrillary tangles, characteristic for the disease, have been shown to accumulate 
iron [Good et al., 1992;Levine, 1997;Sayre et al., 2000;Rottkamp et al., 2000]  
In Huntington disease, iron accumulation has been demonstrated in the putamen, 
caudate nucleus, and globus pallidus by post-mortem studies and MRI studies [Bartzokis 
and Tishler, 2000;Chen et al., 1993;Dexter et al., 1992;Rutledge et al., 1987]. The iron 
excess contributes to oxidative stress, as indicated by protein disruption [Marnett, 
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2000;Stadtman, 2001] and oxidative DNA damage[Alam et al., 1997;Marnett, 2000; 
Poon et al., 2004a;Sanchez-Ramos et al., 1987]. 
Friedreich ataxia was first described by the German physician Nikolaus Friedreich in 
1860 [Friedreich, 1863] and is marked by a genetic mutation causing the mitochondrial 
protein frataxin to be lacking, leading to impaired iron export from the mitochondria, 
cytoplasmic depletion, induction of plasma membrane proteins involved in iron uptake, 
and consequent iron overload [Berg and Youdim, 2006], including excess of iron in the 
dentate nucleus [Koeppen et al., 2007;Waldvogel et al., 1999].  
In Amyotrophic Lateral Sclerosis (ALS), increased serum levels of ferritin have been 
reported [Goodall et al., 2008] and MR images of the brains of ALS patients show iron 
accumulation in the dentate nucleus [Langkammer et al., 2010]. Although origin of iron 
excess in ALS is not yet clear, increased oxidative damage to DNA, lipids, and proteins 
can be seen early in the disease process, which makes it plausible that iron is at least 
partly involved [Berg and Youdim, 2006]. 
Brain MRI evaluation of patients suffering from Neurodegeneration with Brain Iron 
Accumulation usually show iron accumulation in the globus pallidus (typical but non-
specific eye-of-the-tiger sign), the substantia nigra, and the dentate nucleus [Savoiardo 
et al., 1993;Hayflick et al., 2003;Swaiman, 1991;Halliday, 1995] and histopathology 
demonstrates iron excess accompanied by neuronal loss and gliosis [Savoiardo et al., 
1993;Galvin et al., 2000]. It is proposed that accumulation of cysteine, which chelates 
iron, causes oxidative stress and leads to the increase or iron in the basal ganglia [Berg 
and Youdim, 2006;Perry et al., 1985]. 
IRON AND MIGRAINE 
Few studies have been published describing the association between migraine and iron 
levels in the brain. After earlier reports describing functional blood oxygenation level-
dependent MR imaging demonstrating the involvement in pain of several specific brain 
structures, Welch and colleagues focused their attention on the periaqueductal grey 
matter, red nucleus and substantia nigra in relation to migraine [Welch et al., 2001]. It 
was speculated that, since these brain structures in particular show high iron levels and 
are densely populated with neurotransmitters that can generate free radicals, repeated 
migraine attacks and associated repeated hypoxia could result in release of free radicals 
and cell damage. This mechanism could be seen in those brain areas as accumulation of 
iron, similar to the processes already known in other neurodegenerative diseases as 
mentioned above.  
To test this hypothesis, a clinic-based cross-sectional brain MRI study was carried 
out to assess iron levels by measuring transverse relaxation rates [Welch et al., 2001]. 
This study included seventeen migraine patients, diagnosed using International Head-
ache Society (IHS) criteria, seventeen patients with chronic daily headache, and seven-
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teen control participants; aged 20-64 years. Compared with controls, significant higher 
iron levels were found in the periaqueductal grey matter of the migraine and chronic 
daily headache patients. No differences were found between men and women, nor 
between migraine with and without aura. In addition, an association between iron ac-
cumulation and illness duration was found.  
Because no relation was found between increased iron levels and age in this study, 
authors speculated that iron accumulation must be related to repeated headache at-
tacks. Several explanations for the high iron content of the periaqueductal grey matter 
among migraineurs were given by the authors. First, as a result of the migraine related 
pain combined with oxidative stress, this structure could be abnormal highly metabolic 
active in migraineurs, since transferring-receptor binding is proportional to the meta-
bolic activity of the neuron, and in turn may be influenced by nociceptive function. 
Overexpression of transferrin receptors might result in iron accumulation and free radi-
cal cell damage, a process that may be aggravated by eventual hypoperfusion during 
migraine attacks. As a consequence, metabolism and iron uptake in the remaining neu-
rons would be increased, leading to even more iron accumulation. Second explanation 
for high iron concentration is the presence of gliosis, since glial cells have high iron con-
tent, but the authors found no evidence of gliosis on MR images of these participants. 
From this study, it was concluded that iron accumulation in the periaquaductal grey 
matter among migraineurs was the result of an impaired iron homeostasis, possibly 
associated with neuronal dysfunction or damage [Welch et al., 2001].  
To evaluate these interesting findings in a larger, population-based group of mi-
graineurs, brain MR images of 138 migraineurs (IHS criteria) and 75 matched controls 
were analyzed for iron concentration in deep brain nuclei as part of the CAMERA-study 
(Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis) [Kruit et al., 
2009]. Because measurements in older subjects are increasingly influenced by non-iron 
related factors, analyses were separated into subjects younger than 50 years and older 
than 50 years. In the younger group, compared to controls, migraineurs demonstrated 
higher iron concentrations in several nuclei, including putamen, globus pallidus, and red 
nucleus. No differences were found between men and women, nor between migraine 
with and without aura. Among these participants under 50 years, an association was 
found between longer migraine duration and higher iron concentration in putamen, 
caudate nucleus, and red nucleus [Kruit et al., 2009]. These structures are all known to 
be involved in the normal central nociceptive network [Iadarola et al., 1998].  
Data from both studies suggest that repeated migraine attacks, or the accompany-
ing pain, are associated with higher iron concentration in several brain structures in-
volved in central pain processing and migraine pathology. It is not known whether the 
increase in iron is caused by repetitive activation of the pain nuclei or whether the in-
creased iron itself inflicts damage to these structures via free radicals in oxidative stress. 
Furthermore, theoretically, damage of these pain-processing nuclei could lead to chron-
ification of migraine in specific patients. As to date, studies on this subject have a cross-
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sectional design, the assumption that recurring attacks lead to accumulation of iron can 
not be verified. A longitudinal study is needed to follow-up on migraineurs and controls 
to carefully evaluate their general health status, headache history, course of migraine 
over the years, and measurements of brain iron concentration.  
SUMMARY 
During aging, iron accumulates in the brain, specifically in the basal ganglia, following a 
certain distribution pattern. Iron accumulation could be the result of neuronal loss, 
followed by substitution by cells with higher iron loads, or of leakage of the blood brain 
barrier, allowing iron to access the brain in higher concentration. Several neurological 
disorders, as well as migraine, are associated with iron excess in the brain. Higher brain 
iron concentration generates a reactive iron overload, which invades and damages 
neurons and other cells. It is not clear yet whether iron accumulation in basal ganglia 
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Introduction – In the CAMERA population-based MRI study, migraineurs below the age 
of 50 had decreased T2-values indicative of increased iron deposition in several deep 
brain nuclei. Longer migraine history was associated with lower T2-values, suggesting an 
association between migraine attacks and iron accumulation. In the present nine-year 
follow-up study of the CAMERA cohort we re-measured the T2-values in deep brain 
nuclei to assess the evolution over time. 
Methods – Baseline and follow-up T2-values measured in several basal ganglia of 128 
participants (38 control, 90 migraine) were analyzed using quantitative T2 measure-
ments and multivariate regression analysis. 
Results – T2-values of most deep brain nuclei were increased - instead of an expected 
further decrease when only age related iron accumulation would have played a role - 
compared to baseline (both among controls and migraineurs) and were not different in 
both groups. In migraineurs, no differences were found by gender, migraine severity or 
subtype. 
Conclusion – This study did not provide supportive data for migraine related increased 
iron accumulation in deep brain nuclei, but neither is able to reject such hypotheses. 
Increased T2-values probably point at microstructural tissue changes, that counter-
acted earlier accumulated iron effects. We hypothesize that with aging migraine-
induced iron-related brain changes are obscured by age-related other tissue changes.  
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INTRODUCTION 
In normal aging, iron accumulates throughout the brain, particularly in the basal ganglia. 
Iron deposits are visible as diffuse hypo-intense changes in deep brain structures on T2-
weighted and T2*-weighted MR images.1;2 Specific neurodegenerative diseases (e.g. 
pantothenate kinase associated neurodegeneration, but also Parkinson’s and Hunting-
ton’s disease) are associated with increased iron accumulation in specific brain regions. 
In migraineurs, lower T2-values were also found in deep brain nuclei and the peria-
quaductal gray matter.3;4 In the population-based CAMERA MRI-study, we reported 
evidence of increased iron accumulation in the putamen, globus pallidus, and nucleus 
ruber of migraineurs.4 An inverse relationship was found, suggestive of a causal relation 
between recurring attacks and accumulation of iron. Because of the cross-sectional 
design of the study at that time, we could verify this hypothesis. To assess whether iron 
accumulation is indeed associated with recurring migraine attacks, we measured T2 
values in the CAMERA-2 study which is a prospective, nine-year follow-up of the original 
CAMERA cohort.5  
METHODS 
Study population 
In the CAMERA study, we had measured brain iron in 213 participants (138 migraineurs 
and 75 matched controls). Clinical characteristics have been described elsewhere.4 In 
short, participants (mean age 49; 69% female) from the general population were identi-
fied as migraineurs or non-migraine controls according to the International Headache 
Society.6 Both groups had comparable cardiovascular risk profiles. None of the patients 
or controls showed clinical signs of basal ganglia dysfunction at a standard physical and 
neurological examination. 
Magnetic Resonance Imaging 
To guarantee methodological comparability with the original CAMERA study nine years 
earlier, we used the same scanner and scan protocol.4 Whole brain MR images were 
acquired on a 1.5T scanner in Maastricht (ACS-NT; Philips Medical Systems, Best, The 
Netherlands). Images were acquired with 48 contiguous 3-mm axial slices (field of view 
22 cm; matrix, 190-205 x 256). Pulse sequences included a combined proton density 
and T2-weighted fast spin-echo (repetition time/echo time, 3000/27-120) and fluid-




Quantitative T2 measurements were carried out in exactly the same way during 
baseline and follow-up, by applying the same post-processing steps as described be-
fore.4 In short, the observer, who was blinded for patient characteristics, measured 
signal intensities (SIs) of six regions of interest, bilaterally. Regions of interest were the 
same as in the baseline study: putamen, putamen posterior, nucleus caudatus, globus 
pallidus, substantia nigra (pars reticularis and pars compacta), and nucleus ruber. T2 
values were estimated using the expression T2 = (TE2-TE1)/[ln (S1/S2)], where S1 and 
S2 are the measured signal intensities in the early-echo (= proton density, TE1=27 ms) 
and late-echo (= T2, TE2=120 ms) respectively.  
The protocol was approved by the local Medical Ethics Committees and all partici-
pants gave written informed consent. 
Statistics 
To test for any differences in the distributions and means of measured characteristics 
among the study groups, χ2 tests and unpaired t tests were used. Linear regression 
analyses (controlled for age) were used to test for differences in the measured T2 val-
ues. Statistical tests were not corrected for comparison of multiple nuclei. T2 values of 
deep nuclei are greatly influenced by non-iron related changes after about 50 years of 
age. Since baseline analyses had only shown T2 differences between migraineurs and 
controls younger than 50 years old, we also analyzed the follow-up results in stratified 
subgroups younger and older than 50 years.  
RESULTS 
Study population 
In the follow-up CAMERA MRI study, we measured T2 values in 128 of the 
213participants (60%, 38 controls, 90 migraineurs; Table 1). Clinical characteristics of 
migraineurs and controls were similar (all p>0.05; Table 1). Participant characteristics 
were not significantly different between participants (n=128) and non-participants 
(n=85) (all clinical characteristics p>0.05). Only data from participants with follow-up 
MRI available were included in the analyses. Reasons for non-participation in the follow-
up were: lack of interest (n=33); non-neurological co-morbidity (n=20); participation in 
CAMERA-2, but no re-scan (n=22), unable to establish contact before the end of inclu-
sion (n=4); exclusion (n=5); and deceased (n=1). Mean baseline T2-values of non-
participants were significantly lower than of participants, but this effect was similar for 
migraineurs and controls. Clinical characteristics of non-participants at the time of fol-
low-up were not available. 
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Table 1. Characteristics of study participants 
Characteristic Control (n=38) Migraine (n=90) 
Age, mean (SE), yrs 55 (1.3) 58 (0.8) 
Female 68% 67% 
Body mass index, mean (SE) 26 (0.6) 26 (0.5) 
Hypertension (self-reported, doctor-diagnosed) 29% 34% 
Diabetes (self-reported) 2.6% 7.8% 
Smoking, ever 68% 70% 
Smoking, pack-years, mean (SE) 25 (3.5) 17 (2.0) 
Duration migraine history, yrs (SE)   
Until baseline study - 23.7 (1.2) 
Until follow-up study - 30.1 (1.4) 
Estimated total number of migraine attacks (SE)   
Until baseline study - 358 (40) 
Until follow-up study - 508 (61) 
Differences between controls and migraineurs were not significant (p>0.05) 
T2-values 
Mean T2-values of the putamen, posterior putamen, nucleus caudatus, and substantia 
nigra pars compacta were increased compared to baseline in both control and migraine 
groups (p<0.001; Figure 1; Table 2). T2-values of the substantia nigra pars reticularis 
showed a non-significant decrease in controls (95% CI -8.0-0.0; p=0.05) and migraineurs 
(95% CI -4.6- 0.3; p=0.08). T2-values of the globus pallidus remained the same over time 
for both groups (p>0.1). The nucleus ruber showed a different pattern: in controls, mean 
T2-value decreased over time whereas it increased in migraineurs, resulting in a similar 
T2-value at follow-up for migraineurs and controls. Areas of the brain that were evaluated 
by T2-value measurement did not demonstrate focal T2 hyperintense lesions or infarcts. 
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Table 3. Changes of T2 values (SD, in ms) after 9 years follow-up 




95% CI p-value  
(age adjusted) 
Putamen 2.9 (1.6) 3.2 (1.9) -0.6 – 0.8 0.8 
Putamen posterior 2.2 (3.0) 3.6 (3.9) -0.2 – 2.7 0.09 
Nucleus caudatus 3.2 (2.1) 3.2 (2.2) -0.9 – 0.7 0.7 
Globus pallidus -0.4 (4.9) 0.9 (4.5) -0.6 – 3.0 0.2 
Substantia nigra pars reticularis -4.0 (12.2) -2.0 (10.5) -2.0 – 6.6 0.3 
Substantia nigra pars compacta 3.5 (5.5) 3.2 (4.6) -2.5 – 1.3 0.5 
Nucleus ruber -2.3 (13.7) 2.3 (10.8) 0.9 – 10.0 0.02 
Negative numbers indicate a decrease in T2-value between baseline and follow-up 
 
Thus, the changes over the years resulted in similar basal ganglia T2-values at follow-up 
in migraineurs and controls. Cross sectional analyses showed no differences between 
groups at follow-up (Table 3). No differences were found between controls and sub-
groups of migraine with and without aura, nor between men and women (p>0.05). 
Likewise, no differences were found when analyzing only the group younger than 50 
years at baseline (Table 4). Baseline T2-values of followed-up migraine participants 
were still lower than baseline T2-values of followed-up control participants for putamen 
(95% CI -2.0- -0.1);p=0.02), posterior putamen (95% CI -3.1-- -0.7); p=0.02), and nucleus 
ruber (95% CI -10.0 - -1.3);p=0.01) 
 
Table 4. T2 values (SD, in ms) after 9 years follow-up 
    Participants who were younger than 50 yrs 
at baseline 










[95% CI];p-value  
(age adjusted) 
Putamen 78.2 (2.2) 77.5 (3.5) [-2.2-0.2];0.1 77.7 (2.0) 77.0 (2.8) [-2.0-0.5];0.2 
Putamen posterior 75.7 (2.5) 75.4 (5.2) [-2.5-1.0];0.4 75.4 (2.4) 74.5 (3.8) [-2.4-0.7];0.3 
Nucleus caudatus 86.4 (2.4) 85.8 (3.0) [-1.7-0.5];0.3 86.5 (2.3) 85.9 (2.7) [-1.9-0.6];0.3 
Globus pallidus 73.6 (3.0) 73.8 (3.5) [-1.5-1.1];0.8 73.5 (2.3) 73.3 (2.4) [-1.3-1.0];0.8 
Substantia nigra 
pars reticularis 
73.0 (3.3) 73.4 (4.2) [-1.3-1.8];0.7 73.2 (3.6) 73.1 (4.4) [-2.0-1.9];0.9 
Substantia nigra 
pars compacta 
85.3 (2.8) 84.8 (4.0) [-2.2-0.5];0.2 85.4 (2.9) 84.0 (4.1) [-3.2-0.3];0.1 
Nucleus ruber 81.8 (4.0) 82.0 (4.0) [-1.9-1.0];0.5 80.8 (3.6) 81.0 (3.2) [-1.3-1.8];0.8 
T2-values and migraine severity 
Neither T2-values at follow up nor the change in T2-values over the years correlated 
with the estimated number of migraine attacks suffered between baseline and follow 
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up (p-values 0.1-0.9). Migraine activity (defined as having had at least one attack during 
follow-up was also not related to (change in) T2-values. Finally, migraine duration (years 
of migraine) was not associated with T2-values at follow up.  
DISCUSSION 
In contrast to the CAMERA-1 study, we failed to find differences in basal ganglia T2-
values between migraineurs and controls in more or less the same study population 
nine years later. This was true for both the whole population and those under age 50. 
We originally had hypothesized that iron accumulation was due either to disruptive 
iron homeostasis in dysfunctioning neurons or to repeated activation and hyperemia of 
nuclei associated with pain processing during migraine attacks. Although the current 
negative follow-up data do not support these hypotheses, the also do not necessarily 
reject them. In general, in the abcense of focal visible lesions, increase in T2-values can 
be histologically explained by cellular and axonal loss, presence of gliosis, or microin-
farction.7-9  
As once accumulated iron does not disappear from the brain, such T2-increasing 
changes in parenchymal microstructure have probably counteracted and overcome the 
T2-lowering effects of earlier accumulated iron. The disappearance of the earlier differ-
ences between migraineurs and controls might further suggest that diffuse T2-
increasing changes over time are more progressive in migraineurs. Although the current 
data cannot prove this hypothesis, such an observation would be in line with the re-
ported progression of diffuse T2 hyperintensities in the brainstem of migraineurs. 5 A 
technological explanation seems unlikely, since we used the same scanner, scanning 
protocol and post-processing steps.  
The nucleus ruber showed a pattern, different from the other nuclei: mean T2-value 
in the control group decreased, whereas mean T2-value in the migraine group increased 
over the years. The reason for this is unknown. The migraineurs of the current cohort 
did not show visible hyperintense lesions in the nucleus ruber, which could have been a 
plausible cause for the increase in T2-value. Possibly, a migraine-specific process leading 
to increase in T2-signal plays a role, as the nucleus ruber is known to be involved in 
nociception.10 This interesting finding calls for further research on the role of the nucle-
us ruber in migraine.  
The mean age of the cohort was 57 years at follow up, which makes measurement 
of T2-values more susceptible to other age-related effects rather than iron-related 
factors. However, both study groups (migraineurs and controls) aged by the same 
amount of years.  
A potential limitation of the present study is that not all participants at baseline also 
participated at follow-up, limiting the statistical power of the present study and poten-
tially introducing selection bias. Although the clinical characteristics of participants and 
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non-participants were similar, T2-values at baseline were lower in the migraine and 
control non-participants, probably resulting in an overall higher T2-value among the 
participant group at follow up It has to be noticed that T2-weighted images are less 
sensitive to iron accumulation compared to T2*-weighted images. Unfortunately, T2*-
weighted images were not part of the baseline and follow-up scanning protocol. 
Major advantages of the present study are the population-based design with de-
tailed clinical information allowing for sub-group analyses, and the large number of 
unbiased MR measurements at baseline and follow-up for which, importantly, we used 
exactly the same protocols and procedures to ensure technical comparability over time.  
To explain the disappearance over time of the difference in T2 values between mi-
graineurs and controls, we hypothesize that age-related signal increases have counter-
acted the iron-related signal decreases. The current findings, therefore, are not neces-
sarily in conflict with previous findings.  
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KEY FINDINGS 
• Baseline CAMERA study reported evidence of increased iron accumulation (i.e. 
lower T2-values) in deep brain nuclei among migraineurs of the general popu-
lation compared to non-migraineurs 
• Current nine year follow-up study showed an increase of T2-values of most 
deep brain nuclei instead of an expected further decrease 
• T2-values are known to be influenced by other (non-iron) related brain tissue 
changes with aging 
• We hypothesize that with aging migraine-induced iron-related brain changes 
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Objective: To assess volumetric brain changes in migraineurs from the general popula-
tion in comparison with control subjects. 
Methods: Structural brain changes in migraineurs from the general population-based 
MRI Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis (CAMERA)-2 
study were assessed by state-of-the-art voxel-based morphometry. T1-weighted MR 
images of 84 migraineurs (52 with aura; 32 without aura) and 35 headache-free controls 
were evaluated. Regional volumes were compared voxel-wise, corrected for age, sex 
and total intracranial volume, using region-of-interest and whole-brain analyses.  
Results: In region-of-interest analyses, migraineurs showed decreased grey matter vol-
ume in the visual areas V3 and V5 of the right occipital cortex, involved in visual motion 
processing, compared to controls (p<0.05, family-wise error correction). Post-hoc anal-
yses revealed that similar changes were present irrespective of migraine aura status, 
disease activity and attack frequency. In exploratory whole-brain analyses (p<0.001, 
uncorrected; none surviving family-wise error correction for multiple comparisons) we 
identified additional structural differences in migraineurs in other cortical and subcorti-
cal areas, including white matter tracts, that are particularly involved in visual pro-
cessing. 
Conclusions: Migraineurs from the general population showed small volumetric brain 
changes, mainly in cortical areas involved in visual motion processing, compared to 
controls. The presence of morphological changes irrespective of the presence of mi-
graine aura or disease activity suggests that migraine with and without aura share 
common pathophysiological pathways and suggests that these changes are (partially) 
irreversible or might have been present throughout life. 
Abbreviations  
CAMERA=Cerebral Abnormalities in Migraine, an Epidemiological Risk Analysis; 
DARTEL=diffeomorphic anatomical registration exponentiated lie algebra; FLAIR=fluid-
attenuated inversion recovery; MR(I)=magnetic resonance (imaging); ROI=region-of-
interest; SPM=statistical parametric mapping; VBM=voxel-based morphometry; 
WMHs=white matter hyperintensities 
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INTRODUCTION 
Migraine is a common neurovascular brain disorder that is characterized by recurrent 
attacks of headache associated with nausea, vomiting, photophobia, and phonophobia 
(migraine without aura) [IHS IIIb, 2013]. In about one third of migraineurs, attacks are 
associated with transient focal neurologic aura symptoms (migraine with aura) [IHS IIIb, 
2013]. Despite many studies investigating structural changes in migraine [For review see 
May, 2009; Bashir et al., 2013], it remains unclear whether, how, and to what extent 
migraine affects the morphology of the brain.  
Voxel-based morphometry (VBM) is a frequently applied, automated, unbiased, 
whole brain method for comparing grey and white matter density and volume between 
groups on a voxel-by-voxel basis [Ashburner and Friston, 2000]. Several groups have 
reported VBM grey matter changes in migraine, in particular decrease in volume in 
pain-transmitting and pain-processing areas throughout the brain [Coppola et al., 2015; 
Jin et al., 2013; Kim et al., 2008; Hougaard et al., 2015; Liu et al., 2013; Rocca et al., 
2008; Schmidt-Wilcke et al. 2008; Schmitz et al., 2008a; Schmitz et al., 2008b; Valfre et 
al., Headache 2008]. Other groups employed surface-based morphometry and found 
cortical thinning in areas involved in nociception [Messina et al., 2013] and cortical 
thickening in the somatosensory cortex [DaSilva et al., 2007] and visual motion pro-
cessing areas [Granziera et al., 2006; Messina et al., 2013]. Cortical surface area was 
increased in regions involved in executive functions and visual motion processing while 
it was decreased in pain-processing areas [Messina et al., 2013]. 
There is, however, ongoing discussion on: (i) the relevance and specificity of these 
findings; (ii) the possible causes (e.g. changes in metabolism, neurotransmitter levels, or 
functional processing of sensory information); (iii) possible reversibility; and (iv) wheth-
er these changes are a cause or a consequence of migraine [May, 2009; Bashir et al., 
2013]. Moreover, there is debate about the generalizability. The study samples were 
relatively small and primarily included participants with migraine from headache clinics 
who were likely to be affected more severely than average and also overusing acute 
anti-headache medications and suffering from comorbid (psychiatric) diseases which 
both may affect brain architecture [May, 2009; Bashir et al., 2013; Gaul et al., 2011; 
Schmitz et al., 2008a; Van Tol et al, 2010; Riederer et al., 2012; Franklin et al., 2013]. 
Finally, these VBM and surface-based morphometry studies did not always account for 
the increased risk of white matter and other focal ischemic brain lesions that are known 
to be more prevalent among participants with migraine [Kruit et al., 2004; Kruit et al., 
2006; Kruit et al., 2010; Palm-Meinders et al., 2012]. 
In the present study we assessed cerebral grey and white matter volumes of partici-
pants with migraine from the general population by applying state-of-the-art VBM while 
minimizing the potential influence of the various confounders reviewed above.  
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MATERIALS AND METHODS 
Participants 
Participants originated from the CAMERA-2 study (Cerebral Abnormalities in Migraine, 
an Epidemiological Risk Analysis), a nine-year follow-up study on brain changes in partic-
ipants with migraine and controls from the general population. Characteristics of the 
study population and the assessment of migraine have been described in detail else-
where [Palm-Meinders et al., 2012]. In short, participants with migraine (diagnosed 
according to International Headache Society-criteria [2013]) and age- and sex-matched 
controls were evaluated by standardized interview, physical, and neurological examina-
tion, and brain MR imaging. The brain MR imaging protocol included a 3D T1-weighted 
sequence (Maastricht research center only because of technical reasons), suitable for 
VBM analysis, in 128 participants. Characteristics of participants scanned with (Maas-
tricht) and without (Doetinchem) this sequence were comparable. Nine enrolled partic-
ipants were excluded because of large brain infarcts (n=3) or movement artifacts (n=6), 
leaving n=119 participants (69% female; mean age 57 years; migraine with aura n=52, 
migraine without aura n=32, and controls n=35) for VBM analysis. Small, punctate white 
matter hyperintensities (WMHs) as frequently observed in participants with migraine 
[Kruit et al., 2004] were not considered an exclusion criterion. None of the included 
subjects had large, confluent WMHs. The study protocol was approved by the institu-
tional review boards and all participants gave written informed consent prior to partici-
pation. 
Magnetic Resonance Imaging  
Structural whole brain 3D T1-weighted fast field echo images (repetition/echo time 
8.6/4.6 ms; 140 sagittal 1.0 mm continuous slices; 256 mm field of view; acquisition 
matrix 256; acquisition voxel size 1x1x1 mm) were acquired on a 1.5T scanner (ACS-NT; 
Philips Medical System, Best, The Netherlands). In addition, combined proton density 
and T2-weighted fast spin-echo (repetition/echo time 3000/27-120 ms) and fluid-
attenuated inversion recovery (FLAIR; repetition/echo/inversion time 8000/100/2000 
ms) sequences were acquired to check images for structural abnormalities and to assess 
white matter hyperintensities and infarcts. 
Voxel-based morphometry 
One observer (M.C.K.) who was blinded for subject characteristics and diagnosis visually 
screened all MRIs for artifacts and gross structural abnormalities that might interfere 
with further post-processing. MRIs were processed using VBM, applying diffeomorphic 
anatomical registration exponentiated lie algebra (DARTEL) [Ashburner, 2007], with 
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default parameters in SPM8 (Statistical Parametric Mapping, Wellcome Department of 
Cognitive Neurology, London, United Kingdom, http://www.fil.ion.ucl.ac.uk/spm) on a 
MATLAB platform (The MathWorks Inc., Natick, Massachusetts; version 7.4), to localise 
regional differences in grey and white matter volume. The DARTEL algorithm is consid-
ered as a better inter-subject registration than normalisation algorithms in previous 
SPM versions [Yassa and Stark, 2009]. The VBM-DARTEL procedure included (i) checking 
the location of the anterior commissure in raw MRIs, (ii) segmentation into grey matter, 
white matter, and cerebrospinal fluid using the standard SPM8 segmentation algorithm, 
(iii) creation of a DARTEL template derived from non-linear deformation fields for the 
aforementioned segmentation procedure, and (iv) registration of all individual defor-
mations to the DARTEL template. This registration step included modulation, which 
preserved the absolute amount of local grey and white matter volumes in spatially 
normalised images by scaling by Jacobian determinants, i.e. a correction for the dis-
tance over which a voxel had to be stretched or compressed to fit into standard space. 
Subsequently, (v) modulated normalised grey and white matter segments were 
smoothed with an 8 mm full width at half maximum isotropic Gaussian-kernel for statis-
tical comparison. Grey and white matter segments were compared voxelwise between 
(subgroups of) participants with migraine and controls, by creating general linear mod-
els including all subjects with implementation of age, gender, and total intracranial 
volume as covariates. To exclude false positives in non-grey or non-white matter tissue, 
voxelwise comparisons were masked with explicit optimal threshold grey and white 
matter masks created using the SPM Masking Toolbox [Ridgway et al., 2009].  
Statistical analyses 
Statistical Package for Social Science (SPSS Inc., Chicago, IL, USA; version 17.0) was used 
for unpaired t-tests and χ² tests to compare baseline characteristics between partici-
pants with migraine and controls. Voxel-based morphometry analyses included region-
of-interest (ROI) grey matter analyses and whole-brain grey and white matter analyses. 
Region-of-interest analyses 
Based on results from previous VBM and surface-based morphometry studies [Gran-
ziera et al., 2006; Kim et al. 2008; May 2009; May et al., 2013; Messina et al., 2013], ROI 
grey matter analyses were carried out in the prefrontal, insular, anterior cingulate, so-
matosensory and occipital cortex (visual motion processing areas V3 and V5), the thal-
amus and the brainstem (dorsolateral pons and periacqueductal gray). For these ROIs, 
Montreal Neurologic Institute (MNI) coordinates were extracted from the literature (see 
supplementary materials). Participants with migraine were compared to controls by 
applying small volume corrections (pFWE-SVC <0.05) by centering a 10-mm sphere around 
these MNI coordinates. In case of significant findings, post-hoc analyses were per-
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formed to assess whether these changes, as found in comparing participants with mi-
graine with control subjects, were similar in subgroups of participants with migraine. 
For these post-hoc analyses, the average volume of grey matter per voxel in significant 
ROI clusters were obtained for each individual and compared between controls and 
migraine subgroups using full factorial general linear models in SPSS correcting for age, 
gender and total intracranial volume. Subgroups of migraineurs were based on aura 
status (with or without aura), disease activity (>1 year free of attacks [inactive] vs. at 
least 1 attack within the last year [active]) and attack frequency (≤1 [low] or >1 at-
tack/month [high]). In these post-hoc analyses, p<0.05 was considered significant. 
Whole brain analyses 
For whole brain analyses comparing grey and white matter between migraineurs and 
controls, statistical parametric maps were thresholded at a significance level of p<0.05, 
corrected for multiple comparisons using random field theory (family-wise error), which 
is the standard to control for multiple testing in neuroimaging data [Nichols et al., 
2003]. In case of significant findings, post-hoc analyses similar to ROI-analyses were to 
be performed.  
As this is the first VBM-study investigating a population-based sample of participants 
with migraine with a minimum of comorbid factors, we deemed it justified to perform 
additional exploratory whole brain analyses at a less stringent significance level of 
p<0.001, uncorrected for multiple comparisons and minimal cluster sizes of 20 voxels. 
Localization of region-of-interest and whole brain VBM findings 
The location of the most significant voxel in ROI and whole brain VBM clusters of grey 
and white matter volume differences were determined using two detailed atlases in 
consensus [Mai JK, 2007; Talairach and Tournoux, 1988]. To ascertain whether signifi-
cant changes in white matter between participants with migraine and control subjects 
were not due to the occurrence of WMHs, the locations of VBM changes were com-
pared to the location of WMHs. WMHs were segmented semi-automatically as hyperin-
tense lesions on proton density, T2 and FLAIR images using QBrain as described in detail 
elsewhere [Palm-Meinders et al., 2012]. Lesion maps were created per subject and 
registered to MNI152-space. Probability maps, depicting the chance for subjects to have 
a lesion in a specific area, were created for the participants with migraine and controls 
included in the VBM analyses. Finally, these lesion maps were registered to the study-
specific DARTEL space using a 12-parameter affine linear registration. 
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RESULTS 
No significant differences were found for the demographic characteristics of partici-
pants with migraine and those of controls (Table 1).  
 
Table 1 Characteristics of CAMERA VBM study participants 











Age, mean (SE), years 57 (0.7) 55 (1.3) 58 (0.9) 57 (1.4) 58 (1.1) 
Female, No. (%) 82 (69) 25 (71) 57 (68) 21 (66) 36 (69) 
Low education†, No. (%) 60 (50) 17 (49) 43 (51) 17 (53) 26 (50) 
Body mass index, mean (SE) 26 (0.3) 26 (0.6) 25 (0.4) 25 (0.5) 26 (0.5) 
Hypertension‡, No. (%) 35 (29) 9 (26) 26 (31) 8 (25) 18 (35) 
History of stroke‡, No. (%) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 
Current medication, No. (%)      
    Prophylactics N/A N/A 2 (2%) 0 2 (4%) 
    Abortive treatment  N/A N/A 48 (57%) 16 (50%) 32 (62%) 
            Triptans N/A N/A 12 (14%) 4 (13%) 8 (15%) 
            Ergotamines N/A N/A 2 (2%) 1 (3%) 1 (2%) 
Total intracranial volume, mean (SE), liter 1.12 (0.11) 1.14 (0.12) 1.12 (0.11) 1.12 (0.10) 1.11 (0.12) 










Right-handed, No. (%) 102 (86) 31 (89) 71 (85) 29 (91) 42 (81) 
Migraine attacks per year#, mean (SE) N/A N/A 16.5 (2.2) 16.3 (2.7) 16.7 (3.2) 
Migraineurs with high attack frequency#, 
No. (%) 
N/A N/A 42 (50) 17 (53) 25 (48) 
MA=migraine with aura, MO=migraine without aura, DWMH=deep white matter hyperintensity, SE=standard 
error, IQR=interquartile range, No.=number, N/A=not applicable No differences between groups (all p>0.05) 
† Low education indicates primary school or lower vocational education 
‡ Hypertension and history of stroke were self-reported, based on a previous physician’s diagnosis 
# Mean number of lifetime migraine attacks; high migraine attack frequency defined as on average ≥1 attack 
per month 
Region-of-interest analyses 
In ROI analyses (Figure 1), grey matter volumes (pFWE-SVC <0.05, family wise error, small 
volume correction) were smaller in the V3 (pFWE-SVC=0.025; x 26/y -87/z 22) and MT+/V5 
(pFWE-SVC=0.031; x 38/y -76/z 11) areas of the right occipital gyrus of participants with 
migraine compared to those of controls. In post-hoc analyses, migraine subgroups dis-
played roughly the same pattern of grey matter volume decrease in these areas, com-
pared to controls (Table 3). However, in migraineurs with inactive disease (attack-free 
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for more than one year), the decrease in average grey matter volume per voxel in the 
MT+/V5 area was not statistically significant, compared to controls. Decrease of grey 
matter volume in the MT+/V5 was significantly more pronounced in migraineurs with 
active disease and high attack frequency; this was not the case for the V3A area. No 
differences were found between migraineurs and controls for the other ROIs (prefron-
tal, insular, anterior cingulate, somatosensory and, the thalamus and the brainstem).  
 
Figure 1 Region-of-interest analyses 
 
Region-of-interest analyses: axial slices (left) and volume rendering (right) of significant grey matter volume
decreases in the right area V3 (left panel) and V5 (right panel) between migraineurs and controls; color bar
represent Z-values. Pictures depicted in radiological convention. 
 
Table 2 Region-of-interest (ROI) analyses, post-hoc analyses: average grey matter volume per voxel in signifi-
cant ROI clusters comparing migraineurs and migraine subgroups to controls and to each other (small volume 
correction (pFWE<0.05) 

















































MA=Migraine with aura; MO=Migraine without aura 
Active migraine= at least 1 attack within the last year 
HF=High migraine attack frequency and LF=Low attack frequency; cutoff at ‘high’ is >1 attack per month in the 
year before examination. Values represent the mean volume of grey matter per voxel in significant cluster, 
denotation mean (standard deviation). p*=p-value for comparing migraine and migraine subgroups to con-
trols; p†=p-value for comparing migraine subgroups to each other 
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Whole brain analyses 
In whole brain analyses, no significant differences were found in grey or white matter 
when comparing migraineurs to controls (p<0.05, family-wise error correction for mul-
tiple comparisons).  
Exploratory whole brain analyses (p<0.001, cluster extend threshold 20 voxels, uncor-
rected for multiple comparisons) confirmed smaller grey matter volumes in the right occipi-
tal gyrus of patients with migraine compared to controls as already found with ROI grey 
matter analyses. In addition, these analyses demonstrated: (i) larger grey matter volumes in 
the left angular, right middle temporal, left precentral and right superior frontal gyrus, and 
the left lateral geniculate nucleus; (ii) smaller grey matter volumes in the uvula of the left 
cerebellum; and (iii) smaller white matter volumes bilaterally in the occipital lobe and the 
stria medullaris of the thalamus, and unilaterally in the left frontal lobe (Table 4). These 
regional decreases in white matter volume did not correlate with deep white matter hyper-
intensities (Figure 2). Increased white matter volumes were not observed. 
 
Table 3 Increases and decreases in grey and white matter between migraineurs vs. control subjects (p<0.001, 
uncorrected for multiple comparisons, cluster extend threshold 20 voxels) 
 BA L/R DARTEL coordinates kE Z-score 
x y z 
Grey matter increases        
Angular gyrus1 39 L -50 -61 17 432 3.92 
Precentral gyrus2 6 L -51 -1 31 58 3.87 
Middle temporal gyrus3 21 R 54 -32 -6 65 3.52 
Superior frontal gyrus4 9 R 8 53 28 39 3.45 
Lateral geniculate nucleus5 N/A L -21 -27 -5 27 3.33 
Grey matter decreases        
Occipital gyrus6 19 R 26 -87 22 34 3.47 
Cerebellum, uvula7 N/A L -14 -43 -42 68 3.44 
Middle occipital gyrus8 19 R 38 -76 11 44 3.39 
White matter increases - - - - - - - 
White matter decreases        
Occipital white matter1 N/A R 29 -78 15 173 4.48 
Occipital white matter2 N/A R 15 -80 10 386 4.24 
Stria medullaris of thalamus3 N/A R 5 -8 9 90 4.06 
Stria medullaris of thalamus4 N/A L -3 -13 5 44 3.91 
Occipital white matter5 N/A R 42 -69 20 23 3.77 
Occipital white matter N/A R 27 -86 14 105 3.64 
Occipital white matter6 N/A L -22 -70 15 457 3.64 
Occipital white matter7 N/A L -9 -85 5 30 3.34 
Frontal white matter8 N/A L -34 16 19 30 3.23 
BA=Brodmann area, L=left, R=right, kE=cluster size, N/A=not applicable; number 1-8 represent axial slices in 
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DISCUSSION 
In this first population-based assessment of volumetric changes in the migraine brain, 
we found decreased grey matter volume in the V3 and V5 areas of the right occipital 
gyrus in migraineurs compared to controls. Migraine subgroups (i.e. migraine with or 
without aura, active or inactive disease, low or high attack frequency) displayed roughly 
the same pattern of differences in these areas as compared to controls. In exploratory 
whole brain analyses, we identified structural differences in other cortical and subcorti-
cal areas that are particularly involved in sensory processing. 
Cortical areas involved in visual processing 
In the present study, we found decreased grey matter volumes in participants with 
migraine in the visual areas V3 and V5 of the extrastriate cortical areas of the occipital 
gyrus (Brodmann area 19). These cortical areas are involved in motion processing. 
These findings are in line with previous VBM findings [Jin et al., 2013], but seem to con-
tradict the reported cortical thickening in visual processing areas in participants with 
migraine as assessed with SBM [Granziera et al., 2006; Messina et al., 2013]. This ap-
parent discrepancy might, however, be explained by the fact that local grey matter 
volume is not only defined by thickness of the cortex but also by other parameters such 
as cortical folding patterns and total surface area of the cortex.  
Structural changes in cortical visual (motion) processing areas might be related to 
hyperexcitability (i.e. increased cortical responses of the visual cortex to intense, repeti-
tive or long-lasting stimulation) [Aurora and Wilkinson 2007], to distorted cerebral met-
abolic homeostasis or to changes in local neurotransmitter compositions [Reyngoudt et 
al., 2011; Siniatchkin et al. 2012]. Whether such changes are inherited, congenital, or 
acquired remains to be determined. Changes in cortical responsiveness might explain 
well-known clinical symptoms of participants with migraine such as increased sensitivity 
to visual (light), auditory (sound) and tactile stimuli (allodynia). These might also relate 
to lack of habituation to repeated visual stimulation [Ambrosini and Schoenen 2006] 
and interictal deficits in visual motion processing [McKendrick et al., 2004; Shepherd et 
al., 2012] in migraine with and without aura. Cortical spreading depression, the electro-
physiological correlate of migraine aura, might also be due to cortical hyperexcitability 
[Datta et al., 2013; Ferrari et al., 2015] and may begin in visual motion processing areas 
[Hadjikhani, 2001].  
Participants with migraine who had not experienced migraine attacks in the year be-
fore MR scanning (with most being attack-free for over 5 years) still showed changes in 
the right occipital gyrus (V3 area) compared to healthy controls. Therefore, these 
changes appear to be irreversible, at least partially, or may have existed throughout life. 
Grey matter volume decrease in the visual area V5 was more pronounced in active 
migraineurs and those participants with a high attack-frequency which suggests that 
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these volume decrease may (in part) be attack-related. As no significant differences 
were found for these areas between migraineurs with and without aura, these changes 
appear to be independent from presence of aura symptoms. 
Subcortical areas involved in visual processing 
In exploratory whole brain analyses, next to cortical areas involved in visual processing, 
we found increased grey matter volume in the lateral geniculate nucleus in migraineurs 
compared to controls. This thalamic structure processes visual input from the optic 
chiasm to the primary visual cortex [Maleki et al., 2012] and is, like the cortical areas 
found in ROI analyses, associated with visual motion processing [Ungerleider et al., 
1984]. The lateral geniculate nucleus is also thought to attenuate light perception in the 
absence of visual contrast [Hubel and Livingstone, 1990] and has been suggested to play 
a role in photophobia in migraine [Boulloche et al., 2010]. Previous studies already de-
scribed an altered structure [Granziera et al., 2006] of this nucleus and increased oxy-
gen metabolism after visual stimulation [Datta et al., 2013].  
White matter tracts involved in visual processing 
We found bilateral volume decrease in the occipital white matter adjacent to visual 
processing cortical areas. Previously, with diffusion tensor imaging [Granziera et al., 
2006; Rocca et al., 2008], reduced fractional anisotropy was found in white matter 
tracts in the middle temporal area [Granziera et al., 2006] and optic radiation tracts of 
participants with migraine [Rocca et al., 2008], possibly due to increased axonal diame-
ter [Granziera et al., 2006; Rocca et al., 2008]. However, our results of decreased white 
matter volume make less myelination due to abnormal maturation or axonal loss a 
more likely explanation. 
Theoretically, white matter changes as identified with VBM might be caused by 
WMHs which are known to be more prevalent in migraine [Kruit et al., JAMA 2004; 
Palm-Meinders et al., JAMA 2012]. WMHs show a drop in MR T1-signal due to gliosis 
and appear as relatively grey areas and therefore may be falsely classified by VBM seg-
mentation tools as grey matter, despite their location in the deep white matter. How-
ever, the white matter decreases we found in the visual pathways did not co-localize 
with WMHs (Figure 2). 
Differences with previous studies 
Although previous studies notably described difference in areas known to be primarily 
involved in pain processing [Coppola et al., 2015; DaSilva et al., 2007; Hougaard et al., 
2015; Jin et al. 2013, Kim et al., 2008; Liu et al,. 2013; Rocca et al., 2014; Schmidt-Wilcke 
et al., 2008; Schmitz et al., 2008; Valfre et al., 2008], these areas were less prominent in 
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our study. Apart from differences in image acquisition and post-processing, and statisti-
cal thresholding, an explanation might be that the migraineurs from the CAMERA-
cohort have had less frequent exposure to pain compared to the participants from 
headache clinics in the other studies, who tend to suffer from more severe migraines. A 
recent study from Hougaard et al. explicitely found no alterations in cortical structures 
of areas involved in visual processing in migraine patients with visual aura [Hougaard et 
al., 2016]. Again, differences in participant characteristics, numbers of participants, and 
post-processing methods could explain the indiscrepancy of findings across publica-
tions.  
Previous studies showed that adaptive remodeling due to chronic pain might be re-
versible and disappear shortly after adequate therapy [May, 2009; May, 2011]. We 
showed that part of (cortical) grey matter changes were still present long after the last 
migraine attack. 
Our study also has limitations. Despite a reasonably large sample size, we were not 
able to find significant differences, corrected for multiple comparisons, in whole brain 
grey or white matter when comparing migraineurs to controls. Therefore, precaution 
should be taken in interpreting the results of the exploratory whole brain analyses. 
Further, in general, it is difficult to translate VBM changes to specific alterations at mi-
croscopic level as the technique is strongly depending on local T1 MRI signal intensity 
which is influenced by local tissue composition, including number and size of neurons, 
configuration of the extracellular space, presence of specific compounds (like iron, mye-
lin, and neurotransmitters), homeostatic balance, and actual macro- and microvascular 
perfusion. Because whole brain T1 weighted images could be acquired only in the CAM-
ERA-2 MRI study and not also in the 9-year earlier CAMERA-1 baseline study, we could 
not study changes over time. Moreover, the cross-sectional design of our study pre-
cludes analysis of whether the observed structural brain changes are a cause or a con-
sequence of migraine. 
In summary, we found alterations mainly in cortical grey matter structures involved 
in visual motion processing in ‘average’ migraineurs from the general population. These 
findings confirm and extend knowledge from previous surface-based morphometry and 
VBM studies in participants with migraine from specialized headache centers.  
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Objective: To assess whether migraine in the general population is associated with in-
creased risk of systemic right-to-left shunts (RLS) and whether RLS are associated with 
increased prevalence of brain infarcts and persistent recurrence of migraine attacks at 
older age. 
Methods: Brain MRI and transcranial Doppler with air contrast in 166 unselected mi-
graineurs (mean age 6 SD 56 6 7.7 years; 70% women; n = 96 migraine with aura) and 
69 controls (mean age 6 SD 55 6 7.6 years; 65% women) from the general population. 
Results: Participants with migraine with aura more frequently had Valsalva-induced RLS 
(60%), in particular large-sized, compared to controls (42%; odds ratio [OR] 2.1; 95% 
confidence interval [CI] 1.1–3.9; p=0.02) and participants with migraine without aura 
(40%; OR 2.3; 95% CI 1.2– 4.3; p=0.01). They also more frequently had spontaneous RLS 
(35%) than participants with migraine without aura (17%; OR 2.6; 95% CI 1.3–5.6; 
p=0.01) but not compared to controls (26%; OR 1.6; 95% CI 0.8–3.1; p=0.2). Participants 
with migraine with aura and spontaneous RLS more frequently had persistent migraine 
activity (85%) than participants with migraine without spontaneous RLS (63%; OR 3.4; 
95% CI 1.2–10.1; p=0.03). Nine percent of participants with RLS had silent posterior 
circulation infarcts compared to 3% of participants without RLS (OR 2.8; 95% CI 0.9–9.3; 
p=0.08), independent of migraine status. RLS were not associated with white matter 
lesions. 
Conclusions: RLS are more prevalent in migraineurs with aura but do not explain the 
increased prevalence of silent posterior circulation infarcts or white matter lesions in 
migraineurs. Spontaneous RLS are associated with persistent migraine.  
GLOSSARY 
CAMERA=Cerebral Abnormalities in Migraine: An Epidemiological Risk Analysis Study; 
CI=confidence interval; CSD=cortical spreading depression; MB=microbubble; OR=odds 
ratio; PFO=patent foramen ovale; RLS=right-to-left shunts; TCD-c=transcranial Doppler 
with air contrast 
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INTRODUCTION 
Epidemiologic and animal studies have suggested a complex relation between migraine, 
ischemic brain lesions, and systemic right-to-left shunts (RLS).1–6 Participants with mi-
graine had higher prevalence of subclinical deep white matter hyperintensities and 
brain infarcts,2,3,5 migraine with aura was associated with increased prevalence of is-
chemic stroke 1,7 and RLS,4,6 and RLS were more prevalent in patients with cryptogenic 
stroke.8,9 In uncontrolled and open-label studies,10–12 but not in a sham-controlled 
study,13 closing patent foramen ovale reduced migraine attack frequency and risk of 
stroke recurrence.14,15 
In mice, carotid injection of small experimental emboli induced cortical spreading 
depression (CSD),16,17 the electrophysiologic correlate of migraine aura and a putative 
trigger for migraine attacks.18 Altogether, microemboli through RLS might cause cere-
bral ischemia and might trigger attacks of migraine with aura. Thus while in most mi-
graineurs attacks cease, recurring spontaneously at older age,19 in migraineurs with RLS, 
attacks might continue recurring. Most of these data, however, were obtained in pa-
tients from headache clinics who likely were more severely affected than the average 
migraineur. It thus is uncertain whether and to what extent these conclusions can be 
extrapolated to the migraineur at large. 
In the present study, we assessed whether RLS are (1) more prevalent in migraineurs 
from the general population, (2) associated with a higher prevalence of ischemic brain 
lesions on MRI, and (3) associated with ongoing migraine activity. To this end, we as-
sessed and correlated (1) presence, type, and size of RLS; (2) presence and type of is-
chemic brain lesions; and (3) migraine activity, defined as number of attacks in the pre-
ceding year in a cohort of unselected but well-defined migraineurs (n = 203) and controls 
(n = 83) from the general population-based Cerebral Abnormalities in Migraine: An Epi-
demiological Risk Analysis Study Part 2 (CAMERA-2).3 As CAMERA-2 is a 9-year follow-up 
of the CAMERA-1 study,2 in which all migraineurs were initially diagnosed and character-
ized, we could reliably analyze both still active migraineurs in whom attacks were still 
recurring and inactive migraineurs in whom attacks had meanwhile ceased recurring. 
METHODS 
Study population and procedures 
Study participants were invited from the CAMERA-2 study,3 which was primarily de-
signed to assess the prevalence, incidence, and progression of MRI-detectable ischemic 
brain lesions in migraineurs over a 9-year follow-period from the CAMERA-1 study.2 
In CAMERA-1, 295 well-characterized individuals with migraine20 and 140 controls 
who were randomly selected from a community-based study of the general population 
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were included and assessed with brain MRI in 2000.2,21 For CAMERA-2, all original CAM-
ERA-1 participants were invited in 2009 for a follow-up study, which included a struc-
tured computer-guided telephone interview, brain MRI, physical examination, and cog-
nitive testing, all similar to the CAMERA-1 protocols.3 Although MRI scanners had signifi-
cantly improved over the follow-up period, we decided to use the same MRI scanners in 
CAMERA-2 as in CAMERA-1 to preclude finding changes solely due to improved tech-
nology and sensitivity. Transcranial Doppler with air contrast (TCD-c) was performed on 
the same day as the MRI. MRI and TCD-c were performed and read without knowledge 
of migraine status. 
Standard protocol approvals, registrations, and patient consents 
The study was approved by the ethics committees and participants gave written in-
formed consent. 
Outcome measures 
The primary outcome measure was the prevalence of RLS in migraineurs with and with-
out aura compared to controls. Secondary outcome measures were the prevalence of 
ongoing recurrence of migraine attacks (defined as having had at least one migraine 
attack in the previous 12 months)22 in migraineurs with RLS compared to migraineurs 
with migraine but no RLS, and ischemic brain lesions in participants with RLS compared 
to those without. 
RLS 
Presence of RLS was determined by TCD-c in accordance with international guidelines 
and recent recommendations.23 Briefly, the right cubital vein was cannulated with a 20-
G indwelling catheter. A microbubble (MB) medium was prepared by mixing 9 mL saline, 
1 mL air, and 0.5 mL of participants’ own blood at least 10 times vigorously between 2 
syringes connected by a 3-way tap and injected with the participant in supine position 
while insonating the middle cerebral artery through the temporal bone window. We 
used a hand-held 2-MHz probe connected to a Doppler system (Multi Dop T2 [DWL, 
Sipplingen, Germany], Pioneer TC 8080 [Nicolet, Kleinostheim, Germany], or PMD 100 
or ST3 [Spencer Technologies, Seattle, WA]). Signal recording was commenced 10 sec-
onds before application of the contrast medium and halted after 60 seconds recording 
time. The procedure was carried out 3 times in a standardized and fixed order: in the 
first measurement, to detect spontaneous RLS, contrast medium was injected during 
normal breathing. In the second and third measurement, to detect RLS after provoca-
tion, contrast medium was injected and followed after 5 seconds by a 5-second Valsalva 
maneuver. Participants were instructed and coached in a standardized way to press 
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firmly with their mouth closed to produce a Valsalva maneuver. The procedure was 
performed by 2 experienced investigators (H.K. and I.H.P.-M.) blinded for MRI findings 
and migraine diagnosis; participants were instructed not to talk about their medical 
history. TCD-c investigation was performed immediately after MRI on the same day. 
Offline reading started after completion of the study. Two experienced observers 
(R.W.K. and W.H.M.) rated presence and size category of RLS, blinded to participant 
characteristics. Passing MBs were unequivocally characterized acoustically by the typical 
chirping sound and visually by the spike-like appearance in the frequency spectrum. RLS 
were rated according to number of MBs detected during 60 seconds of each TCD-c 
investigation: no RLS (0 MB), small (1–9 MB), or large (> 9 MB). The interrater agree-
ment for presence of RLS was excellent (К = 0.95; p < 0.001). 
MRI 
As suggested recently,24 we replaced the previously used term infarct-like lesions2,3 with 
silent infarcts. Silent infarcts were defined as non-mass parenchymal defects with a 
vascular distribution, isointense to CSF signal on all sequences, and when supratentori-
al, surrounded by a hyperintense rim on fluidattenuated inversion recovery images.2 
Virchow-Robin spaces were excluded based on typical location, shape, and absence of a 
hyperintense rim.2 In the basal ganglia, in order to exclude nonspecific lesions, only 
parenchymal defects larger than 3 mm in diameter were considered.2 Location and 
vascular territory of new and preexisting infarcts were read by 2 experienced neuro-
radiologists (M.C.K. and Junya Konishi), who were blinded to diagnosis. The interrater 
agreement was excellent (k =0.87; p<0.001).2 
White matter lesions were segmented automatically. Deep white matter hyperin-
tensities were located supratentorial and not attached to the lateral ventricle.2 High 
volume of deep white matter lesions (upper 20th percentile) was used as variable. For 
infratentorial hyperintensities, presence vs absence was used. 
Migraine and ongoing recurrence of migraine attacks 
Participants were asked during a telephone interview whether they ever had had mi-
graine attacks and, if so, what the average attack frequency had been prior to CAMERA-
1 and since then. One participant who was classified as control at CAMERA-1 had be-
come migraineur without aura during the follow-up period. Participants who fulfilled 
the criteria of migraine at CAMERA-1 but had stopped experiencing migraine attacks 
during last year of follow-up were considered currently inactive lifetime migraineurs22 
The interview was structured by using personal benchmarks (e.g., pregnancy) for when 
a different migraine pattern had started or stopped.3 These benchmarks were used to 
define periods and to compute the average migraine attack frequency (expressed as 
mean number of attacks per month).Information was collected on migraine prophylaxis 
Chapter 6 
82 
and treatment. Active recurrence of migraine attacks was defined as having had at least 
one migraine attack in the 12 months22 prior to the CAMERA-2 MRI investigation. 
 
Table 1 characteristics of study participants  













Age, mean (SD),y 56 (7.7) 55 (7.6) 56 (7.7) 56 (8.0) 57 (7.6) 
Women 161 (69) 45 (65) 116 (70) 69 (72) 47 (67) 
BMI, mean (SD) 25.5 (3.9) 25.9 (4.1) 25.3 (3.9) 25.3 (3.3) 25.3 (4.6) 
Hypertensiona 73 (31) 22 (32) 51 (31) 31 (32) 20 (29) 
Diabetesa 15 (6) 0 (0) 15 (9)c 7 (7) 8 (11) 
Myocardial infarctiona 5 (2) 3 (4) 2 (1) 1 (1) 1 (1) 
Cardiac arrhythmiaa 25 (11) 5 (7) 20 (12) 15 (16) 5 (7) 
Pulmonary embolisma 3 (1) 0 (0) 3 (2) 1 (1) 2 (3) 
Deep venous thrombosisa 7 (3) 2 (3) 5 (3) 3 (3) 2 (3) 
History of transient ischemic attacka 10 (4) 1 (1) 9 (5) 4 (4) 5 (7) 
History of strokeb 7 (3) 0 (0) 7 (4) 3 (3) 1 (1) 
Smoking  
Ever 
















Postmenopausal state or 
ovariectomy 
86 (66) 23 (58) 63 (70) 35 (66) 28 (76) 










































Migraine years, mean (SD) NA NA 30 (12) 32 (12) 27 (12)d 
Age at migraine onset, mean (SD) NA NA 22 (12) 21 (11) 22 (11) 
Mean attack frequency per year NA NA 12 (22) 15 (24) 19 (21) 
Ongoing recurrence of attacks NA NA 101 (106) 68 (71) 33 (47) 
Abbreviations: ACE=angiotensin-converting enzyme; BMI=body mass index (calculated as weight in kilograms 
divided by height in meters squared); NA =not applicable. 
Active migraine= migraine attacks during the last 12 months. Postmenopausal state= at least 3 months no 
menstruation or history of ovariectomy (unknown postmenopausal state due to hysterectomy in 31). Data are 
presented as n (%) unless otherwise specified. Oral contraceptives and hormonal substitution data presented 
as n (%) among women. Unless indicated otherwise, differences were not significant (p > 0.05). 
a Cardiovascular history self-reported, doctor diagnosed.  
b Ischemic or hemorrhage, self-reported, doctor diagnosed.  
c Compared with controls; p = 0.007.  
d Compared with migraine with aura; p = 0.01. 
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Study population 
Of the 435 original participants of CAMERA-1, 286 (66%) underwent a follow-up MRI 
scan (migraine with aura: n = 114; migraine without aura: n = 89; nonmigraine controls: 
n = 83).3 Mean follow-up was 8.5 years (range 7.9–9.2; SD 0.24 years).3 Of these, 
272/286 (95%) agreed to undergo TCD-c. Usable TCD-c data could be obtained from 
235/272 (86%) participants: in 23/272 (8%), no adequate bone window was found, 
9/272 (3%) had no adequate cubital venous access, and in 5/272 (2%) offline analysis 
was not possible due to technical failures. The 37 participants for whom no usable TCDc 
was available were otherwise comparable to the participants with usable TCD-c data 
with respect to age, sex, cardiovascular history, and migraine status. 
As explained before,3 there were no obvious reasons to assume that there was a se-
rious selection bias from CAMERA-1 to CAMERA-2, which could have materially affected 
the results.3 
Reasons for nonparticipation were no interest (n = 51), inability to visit research cen-
ter (n = 30), claustrophobia (n = 8), and non-neurologic illness (n = 6).3 There was no 
association between participation rate and diagnosis of migraine. Compared to nonpar-
ticipants, participants were slightly younger, more frequently reported high educational 
level, and smoked fewer packyears.3 
Covariates and definitions 
Sociodemographic and medical history characteristics were assessed by telephone in-
terview.3 Cardiovascular risk diagnoses were based on patient report of a physician’s 
diagnosis.3 In women, postmenopausal state was defined as last menstruation at least 3 
months previously or a history of ovariectomy. 
Statistical analysis  
Differences in the distributions and means of characteristics among the study groups 
were tested with x2, 2-tailed Fisher exact, unpaired t, and MannWhitney U test when 
appropriate. The presence of ongoing migraine attack recurrence was examined by RLS 
diagnosis (yes/no) using a model adjusting for age, sex, and postmenopausal state. 
Likewise, using logistic regression, the risk of MRI outcomes was examined by RLS diag-
nosis (yes/ no) and migraine and age as covariates. 
Based on findings in previous studies, we decided beforehand to conduct 3 specific 
analyses. First, because an increased prevalence of RLS had only been found for mi-
graine with aura,4,6 we analyzed the prevalence of RLS separately for migraine with and 
without aura. To detect a difference of 20% in RLS frequency with a power of 0.8 and a 
set at 0.05, we would need 162 participants (total number in 2 arms). Second, because 
silent infarcts were found increased only in the posterior cerebral circulation,2 we ana-
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lyzed their presence separately for this part of the circulation. Finally, because higher 
prevalence of deep white matter lesions was only found in women with migraine,3 we 
conducted this analysis stratified for sex. All performed statistical tests are shown in text 
or tables; reported p values are not corrected for multiple testing as this study was an 
exploratory hypothesis-generating study rather than confirmatory research. Data were 
analyzed using Statistical Software Package for Social Sciences (SPSS version 20.0; IBM, 
Armonk, NY). 
RESULTS  
Clinical and demographic data of the participants are summarized in table 1. Except for 
diabetes, there were no differences between migraineurs and controls in age, sex, or 
cardiovascular history. 
Table 2 summarizes the prevalence of RLS among the various study groups. Of the 
migraineurs with aura, 60% had RLS vs 42% of controls (unadjusted odds ratio [OR] 2.1; 
95% confidence interval [CI] 1.1–3.9; p=0.02) and 40% of migraineurs without aura (OR 
2.3; 95% CI 1.2–4.3; p=0.01). Large RLS were found in 45% of migraineurs with aura vs 
28% of controls (OR 2.1; 95% CI 1.1–4.2; p=0.03) and 20% of migraineurs without aura 
(OR 3.3; 95% CI 1.6–6.6; p=0.01). The prevalence of spontaneous large RLS was low in 
migraineurs without aura (1%) compared to controls (16%) and migraineurs with aura 
(19%). Otherwise, there were no differences in the prevalence of spontaneous RLS 
among the various groups. 
We correlated the presence of total and spontaneous RLS with ongoing recurrence 
of migraine attacks in the last year as shown in table 3. Migraineurs with spontaneous 
RLS more frequently had ongoing recurrence of migraine attacks (76%), vs migraineurs 
without spontaneous RLS (55%) (unadjusted OR 2.6; 95% CI 1.2–5.6; p=0.01). When 
analyzed separately for migraine with and without aura, overrepresentation of partici-
pants with migraine with ongoing recurrence of migraine attacks was only found in 
migraineurs with aura and spontaneous RLS (85%) vs without spontaneous RLS (63%) 
(unadjusted OR 3.4; 95% CI 1.2– 10.1; p=0.02). These results did not change after ad-
justing for age, sex, and postmenopausal state. Furthermore, migraine inactivity was 
not due to higher use of migraine prophylactic agents (data not shown). Mean attack 
frequency was not correlated with the presence or absence of spontaneous RLS (data 
not shown). 
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Table 2. Prevalence of right-to-left shunt types 
Right-to-left shunt Controls 
(n=69) 
Migraine  











Spontaneous 18 (26) 34 (35) 0.2 12 (17) 0.2 0.01 
Small no.(%) 7 (10) 16 (17) 0.2 11 (16) 0.3 0.9 
Large no.(%) 11 (16) 18 (19) 0.6 1 (1)  0.02 0.001 
Total after provocation 29 (42) 58 (60) 0.02 28 (40) 0.8 0.01 
Small no.(%) 10 (15) 15 (16)  0.8 14 (20) 0.4 0.5 
Large no.(%) 19 (28) 43 (45) 0.03 14 (20) 0.3 0.01 
Data are expressed as number (%) 
Small shunt defined as passage of 1-9 microbubbles. Large shunt defined as passage of at least 10 microbub-
bles.  
a P value Controls vs Migraine with aura  
b P value Migraine without aura vs controls  
c P value Migraine with aura vs migraine without aura 
 
Table 3. Prevalence of ongoing recurrence of migraine attacks by presence and subtype of right-to-left shunt 
 Migraine (all)  Migraine with aura  Migraine without aura 
 With RLS Without RLS With RLS Without RLS With RLS Without RLS 
Spontaneous RLS n = 46 n = 120 n = 34 n = 62 n = 12 n = 58 
 Ongoing recurrence 35 (76) 66 (55)a 29 (85) 39 (63)a 6 (50) 27 (47) 
Total RLS N = 86 N = 80 N = 58 N = 38 N = 28 N = 42 
 Ongoing recurrence 57 (66) 44 (55) 44 (76) 24 (63) 13 (46) 20 (48) 
Abbreviation: RLS = right-to-left shunts. 
Data are expressed as n (% ). a p < 0.05 Unless indicated otherwise, differences were not significant (p > 0 .05). 
 
Table 4 and table e-1 on the Neurology® Web site at Neurology.org summarize the 
prevalence of MRI detectable brain lesions by RLS type in the 229/235 (97%) partici-
pants who underwent TCD-c and for whom MRI data were available. Prevalence of 
silent infarcts in the posterior cerebral circulation in participants with RLS (9%) was not 
different from those without RLS (3%; OR 2.8; 95% CI 0.9–9.3; p=0.08). This was irre-
spective of migraine status (data not shown). 
The risk of posterior circulation silent infarcts was further assessed using a multivar-
iate regression model (with migraine presence, RLS presence, and age as covariates). 
Higher age (p=0.004) and possibly RLS (p=0.08), but not migraine (p=0.7), were associ-
ated with an increased infarct risk. No significant associations were found between RLS 





Table 4. Prevalence of MRI findings by RLS type 
 Spontaneous RLS   Total RLS   












Any brain infarct-like lesion 23 (14) 7 (11) 0.6 13 (11) 17 (15) 0.3 
Multiple infarct-like lesions 9 (5) 2 (3) 0.5 3 (3) 8 (7) 0.1 
Silent brain infarct posterior 
circulation 
10 (6) 4 (7) 0.9 4 (3) 10 (9) 0.08 
Infratentorial hyperintensities 23 (14) 13 (21) 0.2 20 (17) 16 (14) 0.6 
High volume deep white matter 
hyperintensities 
31 (19) 13 (21) 0.7 20 (17) 24 (22) 0.4 
Data are expressed as number (%).  
Abbreviations: RLS, Right-to-left shunt; Any brain infarct indicates a brain infarct in any vascular territory. 
Multiple brain infarct-like lesions indicates more than one infarct-like lesion in any vascular territory. High 
volume deep white matter hyperintensities defined as upper 20th percentile. 
Progression DWML : progression yes or no within follow up. 
a P Value: No spontaneous RLS vs Spontaneous RLS b P value : No RLS vs RLS. 
DISCUSSION  
We assessed and correlated (1) presence, type, and size of RLS, (2) presence and type of 
ischemic brain lesions on MRI, and (3) persistent migraine activity in a large and unbi-
ased general population-based cohort of phenotypically well characterized migraineurs 
and controls. We found, first, that in particular large-sized RLS are more prevalent 
among migraineurs with aura but not in migraineurs without aura. Second, migraineurs 
with aura and spontaneous RLS more often had ongoing migraine activity compared to 
migraineurs with aura without RLS or migraineurs without aura with or without RLS. 
Third, participants with RLS did not have more silent infarcts in the posterior cerebral 
circulation, irrespective of whether or not they also had migraine. There was no associa-
tion of RLS with white matter lesions. 
Our finding that RLS are more prevalent in migraineurs with aura from the general 
population is well in line with observations from clinic-based studies4,6 and extends the 
RLS-migraine association from selected severe cases who are attending headache clinics 
to the average patient with migraine with aura. Two previous population-based studies, 
however, failed to find an association between RLS and migraine,25,26 most likely due to 
limited statistical power, use of detection methods with only limited sensitivity to iden-
tify RLS, and, possibly, selection bias. In the first study,25 79% of participants had mi-
graine with aura, whereas in the general population only one third of migraineurs have 
migraine with aura.21 Moreover, in that study, transthoracic echo was used, which is 
known to have a lower sensitivity to detect RLS compared to TCD-c.27 The second 
study26 most likely was underpowered, with only 42 participants with migraine with 
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aura and 44 with migraine without aura. Moreover, RLS might have been missed in 
many participants as the TCD signal was assessed within 10 seconds after injection of 
contrast, which generally is considered too soon.28 Use of TCD-c, which is more sensitive 
to detect RLS than the other methods generally used,27 and the longer time window (60 
seconds), which increases the chances of detecting very small cardiac shunts, may ex-
plain why we found somewhat higher RLS prevalences than were found in other stud-
ies.4,6,25,26 Two clinic-based studies29,30 assessed RLS with TCD-c in chronic (high fre-
quent) migraine but with inconsistent findings: 66%30 vs 37%.29 Control groups such as 
participants with episodic migraine or participants without migraine were lacking in 
both studies. 
The relationship between RLS and migraine with aura is intriguing and might be ex-
plained at least in part by shared genetic factors.31 Alternatively, there might be a direct 
causal relationship.32 In mice, it was shown that carotid injection of small particles or air 
emboli injected could evoke CSD,16 the electrophysiologic correlate of migraine aura 
and a putative trigger for migraine attacks.18 Migraineurs who were injected with agi-
tated saline developed EEG alterations and headache attacks, particularly those with 
large RLS.17 Finally, in a small open-label study, 87% of migraine patients with RLS had a 
50% or greater reduction in migraine frequency when using the emboli-preventing drug 
clopidogrel.33 It has also been hypothesized that substances like amines and other 
chemicals might bypass the pulmonary filter in participants with RLS, precipitating mi-
graine attacks in susceptible individuals.11 A direct relationship between RLS and mi-
graine in at least some people is further suggested by our finding that participants with 
migraine with aura (but not those without aura) more often had ongoing migraine activ-
ity if they also had spontaneous RLS. As TCD cannot distinguish between cardiac and 
pulmonary RLS, we cannot determine which type is most relevant in migraine. Trials 
testing the migraine attack-reducing effect of closing patent foramen ovale (PFO), the 
most frequent cause of RLS,11 traditionally included participants with both migraine with 
and without aura, and participants with Valsalva-induced rather than spontaneous 
PFO.10–13 Whereas retrospective studies10–12 showed promising results, a prospective, 
randomized, sham-controlled trial13 failed to show any effect. Interestingly, preliminary 
results of the open-label but randomized Percutaneous Closure of PFO in Migraine with 
Aura (PRIMA) trial comparing PFO closure with antimigraine medication suggested se-
lective elimination of attacks of migraine with aura in participants in whom large spon-
taneous PFOs had been closed (presented at the Transcatheter Cardiovascular Thera-
peutics Meeting, Washington, DC, September 2014). 
Presence of RLS was not associated with higher prevalence of silent infarcts in the 
posterior circulation; this is in line with studies reporting that RLS is not associated with 
specific ischemic patterns.34 
Furthermore, there was no association of RLS with deep white matter hyperintensi-
ties or infratentorial hyperintensities, which is in line with other studies.35,36 
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The design and study population of the present study allow for a broad extrapola-
tion of the results to the average migraine patient. Although still too small for additional 
subgroup analyses, the study sample should be considered large in view of the fact that 
all participants had brain MRI. Moreover, the study participants were drawn from a 
phenotypically well-defined, general population-based, long-term follow-up study,20,37 
and their clinical characteristics covered a wide range of disease severities and attack 
frequencies. The fact that even patients were included in whom attacks had ceased 
recurring enabled reliable analysis of the relationship between RLS and persistent mi-
graine activity at older age. Compared to methods used in most other studies, TCD-c, 
although less specific for subtype, is more sensitive for detecting RLS. Finally, both TCD-
c and MRI were performed and interpreted by investigators who were strictly blinded to 
the clinical diagnoses and characteristics of the participants. 
Migraine with aura, but not without aura, is associated with increased prevalence of 
in particular large RLS. Spontaneous, but not Valsalva-induced, RLS are associated with 
persistent recurrence of migraine attacks beyond the age most patients normally cease 
having attacks. Finally, RLS were not associated with increased risk of ischemic brain 
lesions, irrespective of comorbid migraine status. 
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Table e-1. MRI findings by RLS type, odds ratio unadjusted [OR] and adjusted [OR] 
Abbreviations: RLS, Right-to-left shunts; Any silent brain infarct indicates infarct in any vascular territory. 
Multiple silent brain infarcts indicate more than one infarct in any vascular territory.   
High volume deep white matter lesions defined as upper 20th percentile  








Any silent brain infarct OR 0.8 (0.3-1.9) OR 0.9 (0.4-2.3) 
Multiple silent brain infarcts OR 0.6 (0.1-2.8) OR 0.8 (0.2-4.3) 
Silent infarct  posterior circulation OR 1.1 (0.3-3.6) OR 1.5 (0.4-5.2) 
Infratentorial hyperintense lesions OR 1.6 (0.8-3.5) OR 1.9 (0.9-4.3) 
High volume deep white matter lesions OR 1.2 (0.6-2.4) OR 1.4 (0.7-3.0) 
Total RLS   
Any silent brain infarct OR 1.5 (0.7-3.2) OR 1.5 (0.7-3.3) 
Multiple silent brain infarcts OR 3.0 (0.8-11.5) OR 3.2 (0.8-12.9) 
Silent infarct  posterior circulation OR 2.8 (0.9-9.3) OR 3.0 (0.9-10.0) 
Infratentorial hyperintense lesions OR 0.8 (0.4-1.7) OR 0.8 (0.4-1.6) 
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The general objective of this thesis was to assess presence and progression of brain 
changes in migraine patients of the population-based longitudinal Cerebral Abnormali-
ties in Migraine an Epidemiological Risk Analysis-study (CAMERA-2 study). Furthermore, 
some possible causes and functional consequences of these brain changes were evalu-
ated. 
Chapter 2 describes the prevalence and progression of brain changes as measured 
by MR imaging and the relation between migraine and brain lesions with cognitive per-
formance. After a nine-year follow-up, there were no differences between male mi-
graine patients and controls in brain lesion presence or progression. Women with mi-
graine, on the other hand, showed higher incidence of deep white matter hyperintensi-
ties. Migraine severity characteristics - number of attacks, duration, frequency - were 
not associated with progression of lesions. Progression was marked by increased num-
ber of new lesions, rather than increase in the size of preexisting lesions. There were no 
differences in prevalence or progression of periventricular white matter hyperintensi-
ties between migraine patients and controls. Infratentorial hyperintensities were also 
found more often among migraine women compared to controls. Again, no relation was 
found with migraine aura or migraine severity. Finally, 10 migraineurs versus none of 
the controls showed new infarcts in the posterior circulation territory. Therefore, 
among females from the general population, migraine is a risk factor for presence and 
progression of white matter hyperintensities. 
The association between migraine and iron in the brain is described in Chapter 3. 
Previously it has been suggested that (the pain of) repeated migraine attacks might 
cause iron accumulation in brain structures involved in central pain processing. In Chap-
ter 4, iron deposition and accumulation in the basal ganglia of the CAMERA-participants 
is evaluated by measuring T2-values at baseline and follow-up time points. At baseline, 
migraineurs below age 50 had decreased T2-values indicative of increased iron deposi-
tion in deep brain nuclei. After nine years, T2-values of most deep brain nuclei were 
increased rather than further decreased as we had expected. Furthermore, there were 
no differences anymore between migraineurs and controls. Possibly, age-related signal 
increases might have counteracted the iron-related signal decreases. 
Chapter 5 describes structural brain changes in the CAMERA-cohort, as measured 
with voxel-based morphometry of anatomic MR images. In region-of-interest analyses, 
migraineurs showed decreased grey matter volume in the visual areas V3 and V5 of the 
right occipital cortex compared to controls. We discuss possible explanations for these 
findings, such as brain changes caused by adaptive remodeling due to chronic pain, 
hyperexcitability, distorted cerebral metabolic homeostasis, and changes in local neuro-
transmitter compositions.  
Several kinds of migraine-associated brain changes are discussed in chapters 2-5. 
The occurrence of ischemia during attacks seems a logical explanation for the develop-
ment of lesions. But ischemia cannot explain all findings. Possible alternative explana-
tions for an association of migraine headache with structural brain changes include: (i) a 
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chronic procoagulatory or proinflammatory state due to endothelial dysfunction or 
elevated homocysteine levels; or (ii) recurrent paradoxical (micro-)emboli as a result of 
right-to-left shunting.  
In Chapter 6, the prevalence of right-to-left shunt (RLS), and its association with is-
chemic brain lesions and migraine persistence is described. Among migraineurs with 
aura, the prevalence of RLS is increased and spontaneous RLS are associated with per-
sistent recurrence of migraine attacks at older age. Valsalva-induced RLS, in particular 
the larger ones, are also more prevalent among migraineurs with aura than among 
controls or migraineurs without aura. Having both migraine with aura and a spontane-
ous RLS increases the likelihood of persisting migraines. Irrespective of having migraine 
or not, individuals with RLS tend to have more often infratentorial infarct-like lesions 
than those without RLS. Migraine with aura (but not without) and RLS are comorbid 
conditions, but the biological mechanism remains speculative. Cerebral emboli are 
probably able to induce migraine symptoms, although this is rare. There is no evidence 
that closure of a RLS modifies migraine frequency. 
Do the brain lesions observed in migraine patients have functional consequences? 
Because of the higher risk in migraine of infarcts in specifically the posterior territory, 
cerebellar functioning of the CAMERA-2 study participants was evaluated by means of a 
robust cerebellar test battery (Koppen, Palm-Meinders et al. Cephalalgia 2017). The 
domains of fine motor skills (Purdue Pegboard), visuospatial ability (Block-design test), 
limb learning (prism-adaptation task), learning-dependent timing (eyeblink-conditioning 
task), and balance capabilities (body-sway test) were analyzed. Migraine patients and 
controls showed similar performance on all cerebellar functioning tests. Those with a 
cerebellar infarct performed similarly, except for a worse assembly task of the Purdue 
Pegboard, which tests fine motor skills. It can be concluded that – despite a higher risk 
of cerebellar ischemic lesions – migraine patients from the general population do not 
show impaired cerebellar functioning. 
In general, white matter hyperintensities are linked to impaired cognitive perfor-
mance. Furthermore, many migraine patients have cognitive complaints during or 
shortly after an attack. Cognitive performance was therefore evaluated in the same 
population at baseline in the CAMERA-1 study and, nine years later, in the CAMERA-2 
study (Chapter 2). Cognitive functioning was similar for migraine patients and controls, 
deep white matter hyperintensities were not related to impaired cognitive perfor-
mance, and migraine had no influence on this association. Participants with high lesion 
load at baseline did not experience greater change in cognitive function at 9-year fol-
low-up than those without high lesion load at baseline. Similarly, there were no signifi-
cant differences between groups with respect to tests of individual cognitive domains. 
In summary, migraine was associated in women with increased risk of brain changes 
and greater progression of existing brain lesions. The underlying pathophysiological 
mechanisms are not yet clear, but both attack- and permanent disease-related mecha-
nisms seem to be involved. The increased prevalence of brain lesions did not result in 
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impaired cognitive or cerebellar performance. Migraine severity was not correlated 
with number of lesions or degree of lesion progression. Our findings are reassuring for 








Het doel van dit proefschrift was het onderzoeken van de prevalentie en progressie van 
veranderingen in de hersenen van migrainepatiënten uit de algemene bevolking in de 
longitudinale CAMERA-2 studie (Cerebral Abnormalities in Migraine an Epidemiological 
Risk Analysis-study). Daarnaast is gekeken naar mogelijke oorzaken en consequenties 
van deze veranderingen. In het kader van mogelijke consequenties is het cognitief en 
cerebellair functioneren van de migrainepatiënten en controles in kaart gebracht. 
Hoofdstuk 2 beschrijft de prevalentie en progressie van hersenlesies, vastgesteld 
door middel van MRI, en de relatie met cognitief functioneren. We hebben aangetoond 
dat, na 9 jaar follow-up, er bij mannen geen verband is tussen migraine en aanwezig-
heid noch progressie van diverse typen hersenlesies. Bij vrouwen met migraine is er 
echter een grotere incidentie van diepe witte stof afwijkingen. Migraine ernstmaten – 
aantal aanvallen, de duur, de frequentie ervan – houden geen verband met de mate van 
progressie. Progressie van witte stof afwijkingen werd vooral gezien als nieuwe lesies, 
minder vaak waren het groter wordende reeds bestaande lesies. Voor wat betreft de 
periventriculair gelegen witte stof afwijkingen: hierin was geen verschil tussen migraine 
en controle deelnemers. Ook infratentoriële hyperintensiteiten zagen we vaker bij 
vrouwen met migraine dan controles. Er werd echter ook hier geen relatie aangetoond 
met migraine aura of migraine-ernst. Tijdens de follow-up periode bleken tien mensen 
met migraine en geen enkele controle proefpersoon nieuwe infarcten ontwikkeld te 
hebben in het posterieure stroomgebied. We concluderen dat het hebben van migraine 
een risicofactor is voor de aanwezigheid en progressie van deze typen hersenlesies bij 
vrouwen in de algemene bevolking. 
Het verband tussen ijzer en het brein in het algemeen en ijzer in migraine-hersenen 
in het bijzonder wordt beschreven in hoofdstuk 3. Het lijkt alsof (de pijn van) herhaalde-
lijk optredende migraineaanvallen geassocieerd is met een hogere ijzerconcentratie in 
verschillende structuren van de hersenen die betrokken zijn bij centrale pijnverwerking 
en migrainepathologie. Het precieze mechanisme is niet duidelijk. In hoofdstuk 4 is 
gekeken naar de aanwezigheid van ijzer en ijzerstapeling in de basale ganglia van de 
CAMERA-deelnemers door middel van metingen van de T2-waarden op MRI tijdens 
baseline en follow-up. Migrainepatiënten onder de 50 jaar hadden namelijk op baseline 
afgenomen T2-waarden, suggestief voor op een verhoogde ijzerdepositie, in diverse 
diepe hersenkernen. Na 9 jaar bleken T2-waarden van de meeste van die kernen echter 
toegenomen te zijn – in plaats van de verwachte verdere afname. Daarbij werd er bij 
follow-up geen verschil meer gevonden tussen migrainepatiënten en controles, in min 
of meer dezelfde groep deelnemers. Verschillende mogelijke verklaringen voor deze 
bevindingen worden besproken in dit hoofdstuk. Eén mogelijkheid is dat de veroude-
ringsgebonden toename van signaal de ijzergerelateerde afname van het signaal te-
genwerkt of verbloemt. 
Hoofstuk 5 beschrijft de structurele hersenveranderingen in het CAMERA-cohort 
gemeten door middel van voxel-based-morphometry. Region-of-interest analyses – 
gebaseerd op eerder werk in dit veld – lieten in de visuele gebieden V3 en V5 van de 
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rechter occipitale cortext kleinere grijze stof volumes zien in migrainepatiënten vergele-
ken met controles. Dit hoofdstuk beschrijft mogelijke verklaringen voor deze bevindin-
gen, zoals dat deze hersenveranderingen veroorzaakt kunnen zijn door aanpassingen als 
reactie op chronische pijn, hyperexcitabiliteit, verstoorde metabole homeostase in de 
hersenen en veranderingen in lokale neurotransmittersamenstelling. 
In hoofdstukken 2-5 zijn diverse migraine-gerelateerde hersenveranderingen be-
schreven. Een logische verklaring voor het optreden van deze schade lijkt ischemie 
tijdens de hoofdpijnaanvallen. Ischemie kan echter niet alle bevindingen verklaren en 
het lijkt erop dat er ook een meer chronische oorzaak is voor de veranderingen, zoals (i) 
een versterkte bloedplaatjesaggregatie of staat van ontsteking als gevolg van en-
dotheeldysfunctie, of (ii) herhaaldelijk optreden van paradoxale (micro-)embolieën als 
gevolg van rechts-links-shunting. 
Hoofdstuk 6 beschrijft de prevalentie van een rechts-links-shunt (RLS) en de relatie 
met ischemische hersenlesies en migraine persistence (=migraineaanvallen blijven hou-
den bij het ouder worden). Bij de migrainepatiënten met aura werd er een hogere pre-
valentie van RLS gevonden en bovendien bleken spontane shunts geassocieerd te zijn 
met migraine persistence. Valsalva-geïnduceerde RLS, met name de grotere shunts, 
kwamen vaker voor bij migraineurs met aura dan bij controles of dan bij migraineurs 
zonder aura. Degenen die zowel migraine met aura als een spontane shunt hadden, 
bleken een groter risico te hebben op het houden van migraineaanvallen op oudere 
leeftijd. Los van het hebben van migraine bleken degenen met een RLS vaker een infra-
tentorieel infarct te hebben dan degenen zonder RLS. Migraine met aura en RLS zijn co-
morbiditeiten, maar het onderliggende mechanisme is niet duidelijk. Cerebrale emboli-
en kunnen wellicht migrainesymptomen veroorzaken, hoewel dit zeldzaam is. Er is tot 
op heden geen overtuigend bewijs dat het sluiten van een RLS invloed heeft op de mi-
graine aanvalsfrequentie. 
Hebben de in migrainepatiënten aangetoonde hersenlesies functionele consequen-
ties? Vanwege de hogere prevalentie van infarcten bij migraine specifiek in het cerebel-
lum, hebben we in het CAMERA-cohort gekeken naar het cerebellair functioneren van 
de deelnemers door middel van een gedegen cerebellaire testbatterij (Koppen, Palm-
Meinders et al. Cephalalgia 2017). De domeinen van fijne motoriek (Purdue Pegboard), 
ruimtelijk inzicht (block-design test), motorisch leren (prisma adaptatie test), geconditi-
oneerde respons leren en executieve functie (eyeblink conditioning test) en balans 
(body-sway test) zijn geanalyseerd. Migraineurs en controles bleken vergelijkbaar te 
scoren op de cerebellaire testen. Degenen met een infarct in het cerebellum scoren ook 
hetzelfde, behalve dat ze de assembly taak van het pegboard minder goed doen (deze 
test fijne motoriek). Migrainepatinënten uit de gewone populatie scoren dus niet slech-
ter dan deelnemers zonder migraine, ondanks dat ze een hoger risico hebben op cere-
bellaire lesies. 
Witte stof afwijkingen zijn in het algemeen geassocieerd met een verminderd cogni-
tief functioneren. Daarnaast hebben veel migrainepatiënten subjectieve cognitieve 
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klachten tijdens en vlak na een migraineaanval. Om die reden is het cognitief functione-
ren in het CAMERA-cohort onderzocht tijdens baseline en na 9 jaar follow-up, zoals 
beschreven in hoofdstuk 2. Cognitief functioneren bleek vergelijkbaar te zijn voor mi-
grainepatiënten en controles. Bij follow-up was de aanwezigheid van diepe witte stof 
afwijkingen niet geassocieerd met cognitief functioneren en de aanwezigheid van mi-
graine had geen invloed hierop. Deelnemers met een hoge lesie load tijdens baseline 
hadden ook geen sterkere achteruitgang van het cognitief functioneren in de 9 jaar 
follow-up periode dan degene die geen hoge load hadden op baseline. 
Concluderend kunnen we zeggen dat migraine bij vrouwen geassocieerd is met een 
groter risico op hersenveranderingen en een grotere progressie van hersenlesies. De 
precieze onderliggende mechanismen zijn niet duidelijk, maar het lijkt erop dat er zowel 
aanvalsgerelateerde alsook meer chronische oorzaken een rol spelen. Hoewel migraine 
een hoger risico op hersenlesies met zich meebrengt, lijkt de aanwezigheid van deze 
lesies geen consequenties te hebben voor de migrainepatiënt voor wat betreft het cogni-
tief of cerebellair functioneren. Daarmee is de boodschap van de bevindingen, zoals 
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